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➣ HMD  hypomethylated domain 
➣ TSS  transcription start site 
➣ RPKM  reads per kilobase of exon per million mapped sequence reads 
➣ SNP  single nucleotide polymorphism 
➣ indel insertion and deletion 
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Abstract 
The genomes of vertebrates are globally methylated, but a small portion of 
genomic regions is known to be hypomethylated. Although hypomethylated domains 
(HMDs) have been implicated in transcriptional regulation in various ways, how a 
HMD is determined in a particular genomic region remains elusive.  
In Chapter 1, to search for DNA motifs essential for the patterning of HMDs, I 
performed the genome-wide comparative analysis of genome and DNA methylation 
patterns of the two medaka inbred lines, Hd-rRII1 (referred to as Hd-rR) and HNI-II 
(referred to as HNI), which are established from two closely related species in Japan, 
Oryzias latipes and Oryzias sakaizumii, respectively, and exhibit high levels of genetic 
variations between them (SNP, ~ 3%). I successfully mapped > 70% of HMDs in both 
genomes and found that the majority of those mapped HMDs are conserved between the 
two lines (common HMDs). While a large part of the common HMDs resided in gene 
promoters, more than half of species-specific HMDs were located in gene bodies or 
outside genes. Unexpectedly, the average genetic variation rates were similar between 
the common HMDs and other genome regions. However, I identified well-conserved 
short motifs (6-mers) that are specifically enriched in HMDs, suggesting that they could 
function in the patterning of HMDs in the medaka genome. 
In Chapter 2, I selected 40 motifs (20 with CpGs and 20 without CpGs) from 
the above identified motifs which are highly conserved in the common HMDs, and 
further characterized them by relating their positions to accessible chromatin across the 
genome. First, I examined DNase-seq signals around selected motifs and found that 
DNase-seq signal exhibits a periodic pattern around some of those motifs, specifically 
within HMDs. Combining these data with nucleosome core positions determined with 
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MNase-seq, I revealed that these 6-mers reside specifically in linker regions within 
HMDs. Furthermore, I indicated that the preferential localization of most of those 
motifs in linker regions does not reflect simple base compositions, suggesting that they 
function in HMD formation as motifs that regulate nucleosome positioning within 
HMDs. 
In Chapter 3, to examine if intrinsic local DNA sequences are responsible for 
differential DNA methylation pattern between the two medaka species, I made 
transgenic medaka carrying constructs including the Hd-rR or HNI-type sequences of 
those HMDs (or its methylated counterparts). I then examined the methylation pattern 
of F1 or F2 blastula-stage embryos of these transgenic lines by bisulfite analysis. 
Unexpectedly, I found that DNA methylation did not occur or occurred only partially, if 
any, in all transgenes irrespective of their original methylation status. These results 
indicated that, unlike in mammals, de novo methylation fails to target exogenous DNA 
fragments in medaka. 
In summary, my comparative analyses of genomes and epigenomes between 
Hd-rR and HNI and subsequent transgenic analyses provide unique insights into the 
mechanisms underlying HMD formation in the vertebrate genomes. 
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General introduction 
Nowadays, the term ‘epigenetics’ is considered to refer to heritable changes in 
gene expression that does not involve changes in underlying DNA sequences. This term, 
which was coined by Waddington in 1942, was derived from the Greek word 
“epigenesis”, which originally described the influence of genetic processes on 
development (http://www.whatisepigenetics.com/fundamentals/). In his report, 
Waddington described that “between genotype and phenotype lies a whole complex of 
development processes”, for which he proposed the name ‘epigenotype’. Furthermore, 
he insisted on the need to discover the processes involved in the mechanism by which 
the genes of the genotype bring about phenotypic effects, and pointed out that the 
important part of such task is to discover the causal mechanisms at work, and to relate 
them as far as possible to what experimental embryology has revealed of the mechanics 
of development. He named such studies ‘epigenetics’ (Waddington, 1942, reprinted in 
2012).  
Since he emphasized the importance of epigenetics, from 1942 until now, 2016, 
the world of epigenetics has continued to expand. During over last 70 years, we have 
obtained so much information in epigenetics from various aspects, which helped us to 
understand the complicated processes linking genotype to phenotype. Now we have 
some fundamental knowledge in this field, which was unknown about 70 years ago. For 
example, DNA is wrapped around histone octamers, thereby consisting of a structure 
called ‘nucleosome.’ Nucleosome composes the higher-order structure, called chromatin 
(for review, see Szerlong and Hansen, 2011). The questions of how DNA is wrapped 
around histone octamers and how nucleosomes are packed have been addressed to 
understand gene regulation, because the resulting chromatin structure greatly affects 
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gene expression (for review, see Wallrath et al., 1994; Li et al., 2007), which could lead 
to the phenotypic changes. One of the so-called ‘epigenetic modifications,’ chemical 
modification to histone proteins such as acetylation and methylation, can alter the 
chromatin structure directly or indirectly (for review, see Li et al., 2007). In addition, as 
another epigenetic modification, DNA methylation is closely related to nucleosome 
packing, and in particular DNA methylation at gene promoters are known to function in 
stable repression of gene expression (for review, see Bird, 2002). The dynamic changes 
in such epigenetic modifications are considered to be essential for development, growth 
and differentiation of eukaryotes. 
From a larger point of view beyond developmental processes, environment, 
aging, and even our lifestyles can affect the epigenetic status in the genome, which is 
sometimes related to diseases. Cancer is the first disease which was reported to be 
associated with epigenetic changes (Feinberg and Vogelstein, 1983). Currently, 
abnormal hypermethylation of tumor-repressing genes and/or hypomethylation in 
oncogenes are known to be strongly associated with cancers (Akhavan-Niaki and 
Samadani, 2013). 
However, despite the accumulated knowledge as described above, we are far 
from complete understanding of epigenetics. One example is the patterning of DNA 
methylation. Needless to say, DNA methylation is one of the most fundamental and 
well-studied epigenetic modifications. Indeed, in addition to gene silencing at promoter 
regions, a wide variety of functions of DNA methylation at gene bodies and intergenic 
regions have been reported (for review, see Jones, 2012). Intriguingly, while the pattern 
of DNA methylation affects cell differentiation, the large part of methylation patterns, 
especially most of the hypomethylated domains, established by the blastula stage, are 
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largely maintained during development and growth (Laurent et al., 2010; Stadler et al., 
2011; Potok et al., 2013; Lee et al., 2015). Thus, it is essential to ask how the 
methylation patterns in these pluripotent cells are determined in the specific regions 
(where to be highly-methylated and where to be hypomethylated) but it still remains 
largely unknown.  
Previous studies suggest that a local sequence rule determines nearby 
methylation status (Lienert et al., 2011; Schilling et al., 2009; Stadler et al., 2011), 
although its entity remains elusive. In this context, I thought that the Japanese killifish, 
medaka, is a very attractive model organism from several reasons (for review, see 
Takeda and Shimada, 2010). The big advantage is that inbred lines are established, and 
high quality genomes are available for two lines, Hd-rRII1 and HNI-II (Kasahara et al., 
2007). It was reported that there is a substantial genetic variation between them 
(Kasahara et al., 2007) but they can mate and produce healthy offspring under 
laboratory conditions. I thought that they have the genome which can be aligned 
reliably to the other one but show high incidence of genetic variations, which should be 
useful to identify conserved sequences between Hd-rR and HNI within HMDs.  
Furthermore, medaka has a compact genome size (~ 800 Mb), which is only 
one-third of the size of human genome (~ 3 Gb). This makes calculation time relatively 
shorter in genome-wide computational analysis. In addition, the data of epigenetic 
modifications including DNA methylation by the previous studies of my laboratory and 
collaborators are available in medaka (Nakamura et al., 2014; Nakatani et al., 2015; Qu 
et al., 2012; Sasaki et al., 2009). Furthermore, most epigenetic studies has focused on 
mammals (human and mouse) and used cultured cells such as ES cells, and thus the 
study using medaka, which is evolutionary distant from mammals, should give us novel 
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insights into distinct and conserved mechanisms of epigenetics in the vertebrate lineage. 
Indeed, recent advances in experimental techniques such high-throughput sequencing 
allowed us to investigate various organisms, leading to the notion that the mechanisms 
discovered in some model organisms are sometime not applicable to other organisms. 
One example is the existence or absence of global DNA demethylation during early 
development. While mammals show global demethylation and re-establishment in early 
embryogenesis (for review, see Wu and Zhang, 2010), some other vertebrates are 
suggested to lack such global clearance of methylation patterns (Macleod et al., 1999; 
Veenstra and Wolffe, 2001; Walter et al., 2002).  
In my doctoral thesis, to understand the patterning mechanisms of DNA 
methylation, I use the medaka system, in particular the two inbred lines Hd-rRII1 and 
HNI-II, which were established from two closely related species in Japan, Oryzias 
latipes and Oryzias sakaizumii, respectively, focusing that there exist a high incidence 
of genetic variations between them. My doctoral thesis consists of three chapters. In 
Chapter 1, I compared DNA hypomethylated domains (HMDs) at blastula cells 
genome-wide between the two medaka species, and identified short DNA sequences 
which are conserved and enriched in the HMDs shared by the two species. In Chapter 2, 
I examined the relationship between identified short sequences and chromatin open 
structure using DNase-seq and MNase-seq data in medaka. In Chapter 3, to examine 
whether sequence differences between Hd-rR and HNI account for the difference in 
methylation status seen in species-specific HMDs, I made transgenic medaka carrying 
the sequences of HMD and performed bisulfite analysis for those fish.  
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Introduction 
Methylation of cytosine at CpG dinucleotides is one of the most fundamental 
epigenetic modifications of vertebrate genomes. DNA methylation is often described as 
‘silencing’ epigenetic mark, as DNA methylation at gene promoters is associated with 
stable repression of gene expression (for review, see Bird, 2002). In vertebrates, a small 
portion of genomic regions are known to be hypomethylated, and such hypomethylated 
domains (HMDs) are often seen in gene promoters (Hendrich and Tweedie, 2003). Most 
of those HMDs serve as a site for binding of transcription factors and accumulate 
histone modification, mostly active and sometimes repressive-type (Andersen et al., 
2012; Jeong et al., 2014; Nakamura et al., 2014) and thereby contribute to 
transcriptional regulation of nearby genes. In addition to these promoter-associated 
HMDs, some of the HMDs are seen in the regions distant from promoters. Recent 
studies have reported a wide variety of functions of DNA methylation at gene bodies 
and intergenic regions such as regulation of transcriptional elongation, splicing, 
alternative promoters, enhancers, and insulators (for review, see Jones, 2012). Hence, 
the establishment of HMDs, in particular, how a HMD is determined in a particular 
genomic region, has been a subject of intense studies in genome science.  
Cis-regulatory sequences are thought to initially determine the epigenetic code, a 
combination of DNA methylation and histone modifications. Indeed, the analysis using 
hybrid mice of two inbred lines demonstrated that DNA methylation patterns are 
regulated by cis-sequences (Schilling et al., 2009). Consistent with this, a transgenic 
approach has revealed that the methylation patterns of inserted DNA sequences 
maintained their original status (Lienert et al., 2011). The strong association between 
genotype and DNA methylation in human family also supports the importance of 
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cis-elements (Gertz et al., 2011). However, consensus DNA sequences that regulate the 
pattern of DNA methylation remain elusive. A simple approach to look for such 
essential cis-elements is to find out evolutionary conserved genomic sequences among 
closely related species and relate them to the epigenetic code. Recent advances in DNA 
sequencing technology have facilitated this approach (Heinz et al., 2013; Kasowski et 
al., 2013; McVicker et al., 2013). However, we still have difficulties to identify 
conserved motifs even in human and mouse which have rich genome and epigenome 
resources, because of their low frequency of genetic variations within populations (~ 
0.1%).  
In this context, the medaka is a particularly useful model system with the high 
quality draft genome (Kasahara et al., 2007) and base-resolution methylome (Qu et al., 
2012). Importantly, the medaka has polymorphic inbred lines from two geographically 
separated populations living in the northern and southern part of Japan. The two 
populations were separated by an appropriate evolutionary distance (4 - 18 million 
years) that is close enough to reliably align noncoding sequences but also entails 
sufficient sequence variations (SNP, ~ 3%) (Kasahara et al., 2007; Setiamarga et al., 
2009; Takeda and Shimada, 2010; Takehana et al., 2003). The two populations were 
originally considered as one species, Oryzias latipes, but recently the northern one was 
described as a new species, Oryzias sakaizumii (Asai et al., 2011). However, the two 
species are biologically similar to each other; they can mate and produce healthy 
offspring under laboratory conditions, even showing hybrid vigor. Thus, the 
transcriptional and epigenetic profiles of the two species might be largely conserved 
under such large genetic variations. Thus, the comparison of the two genomes and 
methylomes thus would provide insights into mechanisms of HMD formation mediated 
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by cis-elements. 
In Chapter 1, I performed the genome-wide comparison of genome and DNA 
methylation patterns of the two medaka inbred lines, Hd-rRII1 and HNI-II, from 
southern and northern species, respectively. I focused on the genome of blastula in 
which all cells retain pluripotency, and the epigenome of this stage is so called 
‘ground-state’. In the aligned genome regions of the two species, the majority of HMDs 
were found to be conserved between the two species (common HMDs). Unexpectedly, 
common HMDs still accumulate genetic variations at a comparable level to that of the 
methylated regions (~ 2.8%). However, I identified short well-conserved motifs that are 
enriched in HMDs. 
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Results 
A majority of HMDs commonly exist in the closely related medaka species 
I first calculated the proportion of HMDs shared by the two inbred lines, 
Hd-rRII1 (referred to as Hd-rR) and HNI-II (referred to as HNI). Dr. R. Nakamura in 
my laboratory previously reported 15,145 HMDs containing at least 10 continuous 
low-methylated (methylation rate < 0.4) CpGs in Hd-rR blastula embryos (Nakamura et 
al., 2014). Based on the same criteria, I identified 16,361 HMDs in the HNI blastula 
embryos using the previously obtained bisulfite-sequencing data (Qu et al., 2012) and a 
newly assembled genome of HNI (available from 
http://mlab.cb.k.u-tokyo.ac.jp/~yoshimura/Medaka/#!Assembly.md). I mapped HMD 
sequences in one species’ to the other species’ genome and checked if the HMDs are 
shared by the two species (Fig. 1-1A). Due to repetitive sequences and deletions (or 
insertions), about 13% and 23% of Hd-rR and HNI HMDs failed to be mapped to the 
other genome, respectively. Of the uniquely mapped HMDs (13,165 in Hd-rR, 12,660 in 
HNI), approximately 95% (that is, ~ 83% of total Hd-rR HMDs, ~ 74% of the total HNI 
HMDs) was commonly found in the two genomes (referred to as ‘common HMDs’) 
(Fig. 1-1B, 1-2). Only small populations (618 or 598 HMDs in Hd-rR or HNI, 
respectively) had no corresponding HMDs in the other species’ genome (referred to as 
‘species-specific HMDs’), even though the sequences were uniquely mapped in both 
genomes. The size of these species-specific HMDs was relatively small compared to 
that of the common HMDs (Fig. 1-3). 
As the HMD generally overlaps with the gene promoter (Nakamura et al., 
2014), I examined if such tendency is also the case for each set of HMDs. I defined the 
position of transcription start sites (TSSs) according to the Ensembl genome database 
第 1 章 
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(http://www.ensembl.org) and classified genomic regions into three regions as follows, 1. 
promoter regions (the regions from 5 kb upstream to 2 kb downstream of TSSs), 2.  
gene bodies (the regions from 2 kb downstream of TSSs to the end of the genes) and 3. 
the regions outside gene. I found that a large part of the common HMDs (76.1%) are 
located at promoter regions (Fig. 1-4, left). On the other hand, less than one-third of 
species-specific HMDs were at gene promoters (29.4% for Hd-rR specific and 27.9% 
for HNI) (Fig. 1-4, middle and right). Instead, about half of the species-specific HMDs 
and about one-fifth of them were found in the region outside genes and gene bodies 
(both exon and intron), respectively. 
 
Species-specific HMDs affect gene transcription 
Next, I examined how each type of HMDs (common or species-specific) is 
reflected in gene transcription of the two species, by conducting a comparison of 
RNA-seq data. I newly obtained about 62.5 million reads from HNI blastula cells, and 
for Hd-rR, I utilized the previous RNA-seq data from d-rR (Nakatani et al., 2015), a 
closed colony line from which the Hd-rR inbred line had been established. After 
mapping them to the Hd-rR genome, genes were isolated and classified according to 
those having common HMDs or species-specific HMDs in their promoter regions or in 
gene bodies. As for the HMDs located in intergenic regions, I searched for their nearest 
genes. In order to compare the relative expression level, I calculated the ratio of RPKM 
(reads per kilobase of exon per million mapped sequence reads), the gene expression 
level normalized by the total number of the mapped reads and the length of exon, of 
d-rR to that of HNI (d-rR / HNI) for each gene. In the genes with common HMDs in 
their promoters, the median of the RPKM ratio was 0.86 (Fig. 1-5, left, green), which 
deviate a little from the ideal figure, 1.0, probably due to slightly different conditions 
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(e.g. sampling timing and experimental procedures) in the two independent RNA-seq 
experiments. In spite of this, I found a significant tendency; the expression ratio of the 
genes with Hd-rR-specific HMDs and HNI-specific HMDs in their promoters was 
significantly higher (0.97) and lower (0.60) than those with common HMDs in their 
promoters, respectively (Fig. 1-5, left, pink and blue). This suggests that the genes of 
which promoters are marked by HMDs tend to express at higher levels than their 
unmarked counterparts. The expression level of each gene in two species which has a 
species-specific HMD in the promoter is provided in Table 1 and Table 2 (Hd-rR 
specific in Table 1, HNI specific in Table 2). On the other hand, in the genes which 
have a HMD in gene bodies or are nearest to each HMD existing in intergenic regions, 
the ratio of RPKM did not significantly change between each gene category (Fig. 1-5, 
middle and right). 
 
Genetic variations between Hd-rR and HNI in HMDs 
High conservation of HMDs in the two divergent genomes could be explained if 
genetic mutation occurs less frequently in those HMD regions. To test this idea, I 
investigated the rate of sequence variations within the common HMDs, species-specific 
HMDs and methylated regions. Unexpectedly, however, the average frequency of single 
nucleotide polymorphisms (SNPs) did not show a big difference among those regions; 
the median was 2.77, 2.75, 2.83 and 2.96% for methylated, common, Hd-rR specific 
and HNI specific, respectively (Fig. 1-6, left). Thus, the incidence of genetic variations 
in common HMDs is comparable to that in the methylated regions.  
In contrast with SNP, the indel (insertion / deletion) rate was higher in the common 
HMDs (Fig. 1-6, right). This might suggest that HMDs marking the promoter are open 
in chromatin structure and more susceptible to insertion/deletion events than compact 
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methylated regions. Indeed, the indel rate was reported to show peaks in the regions 
with the low nucleosome-occupancy downstream of TSSs (Sasaki et al., 2009). The 
indel event, however, is far less frequent as compared with SNP (0.64% (indel) vs 
2.75% (SNP) in common HMDs) and does not affect much on the overall mutation rate.  
Taken together, blastula-stage HMDs are well-conserved between the two medaka 
species in spite of high incidence of genetic variations.  
 
Specific DNA motifs are conserved and enriched in common HMDs 
The above fact that common HMDs exhibit comparable levels of SNPs led me to 
speculate the presence of short crucial DNA sequences that are specifically conserved 
during speciation. To search for such sequences, I examined the occurrence of short 
oligomers and their conservation between the two species in HMDs or in the methylated 
regions. For each of the 2,080 sequences (reverse compliment is excluded) of 6 bp long 
DNA oligomers (6-mers), I calculated their occurrence and mutation index (the 
proportion of mutated to all found 6-mers, Fig. 1-7A) in each region.  
Given that HMDs are predominantly found at gene promoters, certain DNA 
motifs could be enriched simply because they are required for gene transcription, but 
irrelevant to DNA methylation state. To efficiently extract the candidate 6-mers 
essential for HMD patterning, I looked at their mutation index in species-specific 
HMDs where 6-mers relevant to HMD patterning were expected to be normally mutated. 
For this, I utilized the ratio of the mutation index of common HMDs to that of 
species-specific HMDs for assessment. The low value of this ratio indicates that 6-mer 
is preferentially conserved in common HMDs, but not in species-specific HMDs. 
Furthermore, since CpGs tend to be more conserved within HMDs, as they are easily 
lost when methylated (Bird, 1980; Coulondre et al., 1978; Shen et al., 1994), I classified 
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all 2,080 6-mers into two categories by the presence of CpG, and compared their ratio 
separately. As expected, the histograms of oligomers of each category (Fig. 1-7B) 
demonstrate that most of the 6-mers with CpGs and about a half of the 6-mers without 
CpGs are more conserved in common HMDs (the ratio of mutation index is < 1.0). This 
result further confirmed the higher conservation level of non-methylated CpGs in 
HMDs. Then, top 20 most conserved 6-mers in common HMDs (the ratio of mutation 
index is < 0.455 for CpG and < 0.664 for non-CpG) were selected as (Fig. 1-7C, see 
Table 3 and Table 4 to see the ratio of mutation index) and subjected to further analyses. 
They are specifically conserved in common HMDs, and could play a role in HMD 
patterning. 
Then, to examine the enrichment levels of each DNA motif in common HMDs, I 
calculated the ratio of the frequency within common HMDs to that within the 
methylated regions for each 6-mer. The 6-mers with low ratio of mutation index tended 
to be highly enriched in common HMDs. In particular, top 20 selected 6-mers of both 
type (CpG and non-CpG) exhibited significantly higher enrichment levels in common 
HMDs compared to the methylated regions (Fig. 1-8A) or species-specific HMDs (Fig. 
1-8B). These 6-mers are thus specifically enriched HMDs and at the same time, well 
protected against genetic mutations. Finally, I examined the distribution pattern of the 
conserved 6-mers in common HMDs and found that top 20 6-mers of CpG and 
non-CpG are highly accumulated in the HMD region (Fig. 1-9).  
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Discussion 
The initial pattern of blastula-stage HMDs examined in this study has a 
profound effect on gene expression throughout life. Although some methylated genes 
are later activated by demethylation at their promoters in a cell-type specific manner, 
the majority of HMDs in blastula cells are largely maintained during development and 
growth (Laurent et al., 2010; Lee et al., 2015; Potok et al., 2013; Stadler et al., 2011). 
The medaka system has provided a unique tool to gain insights into genome 
evolution and speciation (for review, see Takeda and Shimada, 2010). In this study, I 
performed the comparative analyses of genome, expression profile and DNA 
methylome of the two closely related medaka species, and successfully identified the 
candidate DNA motifs that may participate in the patterning of HMDs. The estimated 
divergence time of the two regional species varies depending on a method of estimation, 
4 - 5 million years ago by a molecular clock hypothesis (Takehana et al., 2003) and 18 
million years ago by a Bayssian model (Setiamarga et al., 2009). In spite of high 
accumulation of genetic variations during this long separation time, the two populations 
had long been considered as a single species, Oryzias latipes. In 2011, however, the 
northern population was described as a new species, Oryzias sakaizumii (Asai et al., 
2011), which is still controversial in the medaka community. In any case, their 
divergent genetic backgrounds with nearly identical biological features allowed me to 
survey functional cis-elements throughout the genome. Furthermore, the high quality 
draft genome of HNI 
(http://mlab.cb.k.u-tokyo.ac.jp/~yoshimura/Medaka/#!Assembly.md), recently produced 
in addition to Hd-rR, greatly facilitated aligning homologous sequences in the two 
genomes.  
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As expected from their similar biological features, the pattern of HMDs was 
found to be highly conserved between the two species. However, I identified a small 
population of the HMDs (~ 5% of the mapped HMDs of each species) that were only 
found in one species. I found that the genes of which promoters are marked by 
species-specific HMDs tend to express at higher levels than their unmarked counterparts 
(Fig. 1-5, left). This result demonstrated that species-specific HMDs in promoter 
regions could contribute to species-specific gene transcription. This result is consistent 
with the previous report of human family that allele-specific DNA methylation accounts 
for differences in gene expression levels between alleles (Gertz et al., 2011). However, 
it should be noted that interpretation of the blastula RNA-seq data is complicated by the 
presence of maternal transcripts, although the maternal expression profile is expected to 
reflect the initial HMD pattern as the blastula HMDs tend to be largely maintained 
during development and growth (Laurent et al., 2010; Lee et al., 2015; Potok et al., 
2013; Stadler et al., 2011). 
Interestingly, the majority of the species-specific HMDs marks the gene bodies 
or intergenic regions. This is a sharp contrast to the common HMDs which mostly 
reside at gene promoters. Consistent with my finding, Hernando-Herraez et al. (2015) 
reported that most of human-specific DMRs (differentially methylated regions) 
identified by comparison with non-human primates are located in regions distal to TSSs, 
although they examined differentiated cells, blood cells, with different methods for 
identification of the targeted regions. DNA methylation in gene bodies or 
promoter-distal regions is thought to have diverse functions depending on context, such 
as transcriptional elongation, alternative splicing, control of alternative promoter usage, 
and alteration of activity of enhancer or insulators (for review, see Jones, 2012), and 
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thereby affects gene expression either positively or negatively. Indeed, in my study, 
species-specific HMDs located outside gene promoters did not show any correlation 
with the average relative transcription levels. Notably, the comparison between chick 
inbred lines demonstrated that DMRs responsible for differences in immune response 
reside in gene bodies as well as promoters (Li et al., 2015). Taken together, although 
about 13 or 23% of the HMDs are unmapped in each species, the species-specific 
HMDs most likely confer species-specific morphological and physiological characters 
in medaka species identified in previous studies (Ishikawa et al., 1999; Kimura et al., 
2007; Tsuboko et al., 2014) and thus will be interesting targets for the future study of 
speciation. 
Species-specific HMDs greatly helped in identifying the conserved short 
sequences in HMDs. These sequences are specifically enriched in the common HMDs. 
Furthermore, they have been protected against genetic mutations for 4 - 18 million years. 
Importantly, this specific protection is not observed, when they are located outside the 
HMD. These facts suggest that the identified short sequences play an important role in 
initial patterning of HMDs in the blastula genome (Fig. 1-10). Thus far, many attempts 
have been made to identify essential sequences for DNA hypomethylation (Brandeis et 
al., 1994; Dickson et al., 2010; Lienert et al., 2011; Macleod et al., 1994). Recently, 
computational analyses addressed how DNA motifs determine the epigenetic status 
(Luu et al., 2013; Whitaker et al., 2015). My identified sequences only partially 
overlapped with those reported motifs, raising the possibility that essential motifs vary 
among species or unknown logic works behind these various motifs. Furthermore, while 
some of my identified sequences partially overlapped with known binding motifs, more 
than half of them exhibited no similarity with known motifs (Table 3 and Table 4). In 
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any case, I believe that further functional studies of the identified motifs will provide 
insight into molecular mechanisms underlining the establishment of HMDs, an essential 
process of genome function.  
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Chapter 2:                          
Analysis of the relationship between conserved 
motifs and chromatin open structure 
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Introduction 
In Chapter 1, through comparative analysis between the two genomes of the 
polymorphic medaka species, Hd-rR and HNI, I identified the short sequences (6-mers) 
that are well conserved specifically within the common HMDs even under high 
incidence of genetic variations. These sequences are indeed significantly enriched in the 
common HMDs, suggesting that they are good candidates of the DNA motifs essential 
for the formation of HMDs in the medaka genome. In this chapter, I further 
characterized those sequences by relating them to accessible chromatin across the 
genome. 
Regulatory DNA regions in the genome have often been analyzed by the DNase I 
sequencing technique (DNase-seq) that identified accessible chromatin regions as 
DNase I hypersensitive sites (DHSs). This technique, combined with high-throughput 
sequencing, can globally identify accessible chromatin regions (Neph et al., 2012). 
Indeed, mapping DHSs has historically been a valuable tool for identifying all different 
types of regulatory elements because accessible chromatin harbors promoters, enhancers, 
silencers, insulators and locus control regions (Boyle et al., 2008; Crawford et al., 2006). 
When the chromatin state around genes is closed, the genes are no longer accessible to 
most transcription factors. Furthermore, DNase I is known to selectively digest 
nucleosome linkers when the chromatin state is open, while DNA regions tightly 
第 2 章 
本章については 5年以内に雑誌等で刊行予定のため、非公開。 
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wrapped in nucleosome is intact, i.e. closed state of the chromatin (Fig. 2-1). This 
allows for mapping the nucleosome position in open chromatin genome-wide (Zhong et 
al., 2016). Interestingly, it was reported that DHSs tend to exhibit low DNA methylation 
levels (Thurman et al., 2012), suggesting a connection between chromatin accessibility 
and epigenetic modification.  
Nucleosome positioning along the DNA is known to play a crucial role in 
chromatin accessibility (Bassett et al., 2009). The nucleosome is a basic packaging unit 
of chromatin consisting of 147 base pairs (bp) DNA wrapped around a histone octamer. 
Nucleosomes are connected by linker DNA with a variable length in the range about 20 
- 90 bp, forming nucleosomal arrays (one-dimensional ‘beads on a string’), which is the 
fundamental building block of chromatin structures (for review, see Szerlong and 
Hansen, 2011). Positioning of nucleosomes affects accessibility of DNA binding 
proteins to DNA and thereby influences gene transcription (Li et al., 2007; Wallrath et 
al., 1994). In many eukaryotes, nucleosome arrays have been reported to be highly 
phased downstream of TSSs, in other words, nucleosomes exhibit binding to a specific 
region rather than more normal random binding (Chen et al., 2013; Lantermann et al., 
2010; Mavrich et al., 2008; Ponts et al., 2010; Wu et al., 2014; Yuan et al., 2005), which 
could facilitate gene transcription. Intriguingly, the nucleosome structure is known to 
change according to the epigenetic status. Nakamura et al. (2014) reported in the 
medaka genome that, across the boundary of some HMDs, the chromatin status shifts 
from ‘packed’ (methylated) to ‘loose’ (hypomethylated); the average nucleosome core 
signals exhibits a clear 170 bp periodic pattern outside HMDs but the peak becomes low 
and less defined inside HMDs (Nakamura et al., 2014). Taken together, epigenetic 
modifications, nucleosome positioning and chromatin accessibility could collectively 
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regulate gene transcription in the genome. This notion led me to speculate that the short 
sequences I identified in Chapter 1 could participate in any of these processes.  
In Chapter 2, I characterized the identified short sequences by DNase-seq and 
found that in HMDs, some of them preferentially localize in the linker region of the 
nucleosome array. I will discuss the significance of this finding in terms of DNA-guided 
nucleosome positioning in the vertebrate genome, which is still controversial in 
vertebrate genomes.  
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Results 
I selected top 20 of conserved short sequences, from those with CpGs and 
without CpGs (Fig. 2-2, top), which are enriched in HMDs, and focused on these 
sequences in the following of my experiments. They will be sometimes referred to as 
selected top 20 with CpGs and without CpGs, respectively. 
 
DNase-seq signals often show periodic distribution around the selected motifs 
To relate the location of the selected top 20 to the chromatin accessible region, 
I utilized the DNase-seq data of d-rR blastula cells done by Dr. R. Nakamura in my 
laboratory (unpublished). Dr. Nakamura observed that DHSs were highly enriched in 
HMDs (Supplementary figure S1); 84.8% of HMDs contained at least one DHS and 
40.7% of DHSs are found in the HMD which constitutes only 3% of the blastula 
genome. Notably, DNase-seq signal in HMDs showed the periodic pattern of peaks of 
approximately 200 bp intervals (Supplementary figure S1), suggesting that the DNase 
I cleavage pattern in the medaka blastula genome represents arrays of accessible 
nucleosome linkers in HMDs (Nakamura et al., unpublished). 
     I first examined the profiles of DNase-seq signal around each identified 6-mer. 
Fig. 2-2 shows the DNase-seq profile centered by selected top 20 sequences with CpGs 
(left) and without CpG (right), together with the average of selected top 20 and all other 
6-mers in each category (CpG or non-CpG). At first glance, the pattern varies from 
sequence to sequence, and a majority of them show essentially a pattern similar to that 
of other non-selected 6-mers in HMDs. However, I noticed that some of the selected top 
20 with CpGs and without CpGs exhibit a strong periodicity within HMD, while the 
others do not. In the methylated region, no such periodic pattern was observed. 
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Although my classification was rather arbitrary, I categorized the top 20 into four 
categories in terms of periodicity, strong, intermediate, weak and no periodicity. Out of 
40 selected 6-mers, five showed strong periodicity, three for intermediate and ten for 
weak periodicity in their vicinity. No such periodicity was found in the remaining 
twenty-two 6-mers. The peaks are highest at the center and the intervals of them were 
approximately 200 bp, both of which tendency were shared by all 6-mers showing the 
periodical pattern. These results suggest that some selected 6-mers tend to be located in 
nucleosome linker regions in HMDs, as the peak of DNase-seq signals in open 
chromatin is known to correspond to the nucleosome linker region (Zhong et al., 2016). 
 
The selected motifs are distributed in linker regions within HMD 
The above findings led me to examine the relationship between the position of 
the selected 6-mers and nucleosomes in HMDs. I focused on the selected 6-mers of 
which the DNase-seq profiles show strong and intermediate periodicity (altogether eight, 
three for CpG containing and five for non-CpG), and related their positions to that of 
nucleosome linkers and cores.  
Nucleosomes are known to be highly phased downstream of TSSs in many 
organisms (Chen et al., 2013; Lantermann et al., 2010; Mavrich et al., 2008; Ponts et al., 
2010; Wu et al., 2014; Yuan et al., 2005). Given that most of the HMDs overlap 
promoter regions (Nakamura et al., 2014), phased nucleosome patterns could be 
reflected in the observed periodic pattern of DNase-seq signals around the selected short 
sequences within HMD. To test this possibility, I examined the spatial relationship 
between selected 6-mers and nucleosome cores within HMDs. The positioning score of 
nucleosome cores was calculated from the previously generated data of micrococcal 
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nuclease-digested chromatin (MNase-seq) from Hd-rR blastula-stage embryos (Sasaki 
et al., 2009). MNase-seq has widely been used to determine nucleosome occupancy 
genome-wide and nucleosome core positioning score can be used as an indicator of the 
probability that nucleosome core are located to each region. I designated the position of 
each 6-mer within or outside HMD as position 0 and examined the profiles of 
nucleosome core positioning score around each selected 6-mer. 
Around each 6-mer showing strong periodicity (Fig. 2-3, upper), nucleosome 
core positioning score determined by MNase-seq (blue line) showed strong periodic 
patterns and the valleys of the nucleosome core positioning score were mostly in phase 
with DNase-seq signal peaks (red line). This indicates that nucleosomes are highly 
phased around these 6-mers within HMDs and that the DNase-seq peak corresponds to 
the linker DNA region. Notably, the nucleosome core positioning score showed the 
lowest value at position 0, indicating that these 6-mers reside preferentially in linker 
DNA regions within HMDs. As for the three 6-mers with intermediate periodicity (Fig. 
2-3, lower), they also exhibit nucleosome phasing in their neighboring regions and their 
preferential localization in linker regions, but such tendency is weak as compared with 
6-mers showing strong periodicity.  
  
Preferential localization of the selected motifs in linker regions does not mostly 
reflect the simple base composition 
In general, the nucleosome core is known to favor GC-rich sequences and 
disfavor AT-rich sequences such as poly (dA:dT) (Nelson et al., 1987; Tillo and Hughes, 
2009) (see Discussion). This fact raised the possibility that the five selected 6-mers with 
strong periodicity of DNase-seq signature distributed in linker regions simply because 
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their base composition is unfavorable for nucleosome core formation. To test this 
possibility, I examined the distribution pattern of the 6-mers in which the base 
composition is the same as the selected 6-mers but the order was reversed (Fig. 2-4). I 
examined the five 6-mers with strong periodicity and obtained the similar results for 
these 6-mers, except for CGCTAG. For example, while one of the selected 6-mer, 
GCTAGC, which showed low ratio of the mutation index (common / Hd-rR specific), 
exhibited the strong periodic distribution of nucleosome core positioning score within 
HMDs (blue line), its base-reversed version, CGATCG, exhibited no periodicity (green 
line). This result indicates that the distribution of specific motifs in linker regions does 
not simply reflect their base composition. As for CGCTAG, the reverse sequence also 
exhibits periodicity (Fig. 2-4), suggesting that the base composition is important for 
periodic distribution in this case. 
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Discussion 
The selected 40 6-mers (selected top 20 with CpG and without CpGs) I 
examined here were selected based on the conservation between Hd-rR and HNI and 
specific enrichment in common HMDs. I speculated that those 6-mers tend to reside in 
accessible chromatin in HMDs, because they may need to interact with nuclear proteins 
and epigenetic machinery to exert their effects. However, the DNase-seq analysis 
demonstrated that nearly half of the 6-mers exhibited no such preferential localization to 
the accessible chromatin region. A part of them show similarity with the binding sites of 
known transcription factors (TFs) (Table 3 and Table 4), suggesting that they could 
recruit such TFs and direct transcriptional activation. At the moment, I do not know the 
reason why they are not localized in accessible chromatin; they might work at later 
stages.  
By contrast, a few, but not many, 6-mers shows preferentially localization to 
the accessible regions. The analysis with the MNase-seq data further demonstrated that 
they tend to be located in the nucleosome linker. Importantly, this pattern was 
specifically observed within HMDs, suggesting their HMD-specific roles in nucleosome 
positioning. Interestingly, the 6-mers with strong periodicity do not show any homology 
with sequences of known TFs (Table 3 and Table 4). A simple idea is that the structure 
of these sequences may be intrinsically unfavorable for nucleosome core formation, 
although I cannot rule out the possibility that unknown proteins bind to those 6-mers 
and influence nucleosome positioning.  
     In principle, nucleosome organization can be guided both by intrinsic sequence 
preference and by the action of trans-acting factors (Beh et al., 2015; Hughes et al., 
2012; Kaplan et al., 2009; Struhl and Segal, 2013; Zhang et al., 2009). Intrinsic 
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determinants or DNA preferences have been proposed; for example, AT-rich sequences 
for linker DNAs and GC-rich for nucleosome cores (Nelson et al., 1987; Tillo and 
Hughes, 2009). Genome-wide nucleosome mapping in the yeast (Kaplan et al., 2009) 
and Tetrahymena (Beh et al., 2015) genomes also demonstrated the strong dependency 
of nucleosome positioning on local DNA sequences, i.e. DNA-guided nucleosome 
positioning. However, these intrinsic sequence-based rules have failed to work in the 
genomes of more complex organisms such as human (Valouev et al., 2011), suggesting 
much greater roles of trans-acting factors in these organisms. In this context, my finding 
of periodic 6-mers is very important in that it suggests the presence of a novel 
DNA-guided nucleosome positioning in the vertebrate genome. Notably, the sequence 
feature of those 6-mers apparently contradicts the previously reported global sequence 
preference of nucleosomes; in spite of their preferential localization in the linker region, 
they are not AT-rich. Furthermore, most of them may work as motifs but not as simple 
sequence-composite preferences.  
Taken together, although the molecular mechanisms remain unknown, my study 
focusing on the conserved motifs in the common HMDs provides insights into 
sequence-based mechanisms for HMD formation and nucleosome positioning.  
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Chapter 3:                          
Analysis of DNA methylation patterns of 
transgenic medaka carrying HMD sequence 
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Introduction 
During DNA methylation processes at CpG sites, two distinct mechanisms are 
known to work; one is de novo methylation, and the other is maintenance methylation. 
In early development of mammals, global DNA demethylation occurs genome-wide 
after fertilization, and a new methylation pattern is established subsequently (for review, 
see Wu and Zhang, 2010). This establishment process is governed by de novo 
methyltransferases, DNMT3a and DNMT3b (Okano et al., 1999). These methyl marks 
are inherited to daughter cells during development through maintenance 
methyltransferase, DNMT1, which has a preference for hemi-methylated DNA (Bestor 
et al., 1988; Bestor and Ingram, 1983; Hermann et al., 2004). While the global 
demethylation is a hallmark of early embryogenesis in mammals, several studies 
demonstrated the absence of global demethylation in other animals such as zebrafish 
and Xenopus (Macleod et al., 1999; Veenstra and Wolffe, 2001). Also in medaka, there 
is a report suggesting the lack of global demethylation during early embryogenesis 
(Walter et al., 2002), although it only investigated DNA methylation at limited sites 
(CCGG).  
In Chapter 1, I demonstrated that the majority of the mapped HMDs are shared 
by the two medaka species, Hd-rR and HNI, while a small portion of those HMDs (~ 
5% of the mapped HMDs of each species) are species-specific HMDs which have the 
methylated counterparts in the other species’ genome. I identified the 6-mers which are 
specifically conserved in the common HMDs. These results suggest that these motifs 
could act for the patterning of HMDs. Furthermore, the enrichment level of these 
conserved 6-mers was significantly low in species-specific HMDs than in common 
HMDs (Fig. 1-8B). These observations led me to speculate that differences in the 
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genomic sequences itself could account for differentially methylated patterns between 
the two species. In other words, differentially methylated patterns are intrinsically 
created by DNA sequence motifs. 
 In mouse stem cells, introduced DNA fragment recapitulated the methylation 
patterns of their endogenous sites (Lienert et al., 2011), which was the basis of my 
above speculation. I further speculated that the methylation pattern of a transgene could 
recapitulate that of its endogenous site also in medaka. However, given that the 
establishment processes of DNA methylation in early embryos may vary between 
medaka and mammals, I wanted to investigate whether introduced sequences of HMD 
and their methylated counterparts could recapitulate the DNA methylation status of their 
original sites. To address this, I made transgenic medaka fish which carry the sequence 
of HMDs (or its methylated counterparts) and its flanking regions, and examined DNA 
methylation patterns in those regions of F1 or F2 blastula-stage embryos by bisulfite 
analysis.  
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Results 
Transgenes are partially methylated in HMD-containing transgenic medaka 
 In order to examine whether the difference in the methylation patterns in 
identified species-specific HMDs are caused by intrinsic sequence differences between 
the two medaka genomes, I made a series of transgenic medaka which contain HMD 
sequences. The overview of the experiment is shown in Fig. 3-1. For making transgenic 
lines, I selected the HMDs which cover promoter regions, and made constructs which 
contain the sequence (0.6 – 1.5 kb) of a species-specific HMD or its methylated 
counterpart. The constructs contained the β-actin promoter that drives the GFP 
expression in order to detect the presence of transgenes. These sequences were flanked 
by I-SceI sites (Rembold et al., 2006) to facilitate integration. The constructs I made 
included those containing the HNI methylated domain for the analysis of Hd-rR specific 
HMDs (Fig. 3-2), Hd-rR methylated domains for HNI specific HMDs (Fig. 3-3), and 
hypomethylated domains for common HMDs (Fig. 3-4). For a technical reason (Hd-rR 
fish spawn less eggs than d-rR), the injected host was always the d-rR line, a closed 
colony line from which the Hd-rR inbred line had been established. The methylation 
status of injected DNA fragments and their counterpart host regions was analyzed in 
genome DNAs extracted from F2 blastula embryos, unless otherwise noted (Fig. 3-4, 
HMD-1).  
 In total, seventeen transgenic lines of seven HMDs were established in d-rR 
hosts. As for the Hd-rR specific HMD, I obtained one line which has the methylated 
counterpart of the HNI genome (Fig. 3-2). As for HNI specific HMD, I obtained total 
seven lines for three HMDs (Fig. 3-3); five of them have Hd-rR methylated domains 
(left, one for HMD-1, two for HMD-2 and two for HMD-3) and two have HNI 
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counterparts (right). As for the common HMD (Fig. 3-4), I obtained total nine lines of 
three HMDs; four of them have Hd-rR sequence of the common HMD (left, three for 
HMD-1 and one for HMD-3) and five have the HNI counterparts (right, one for HMD-1, 
two for HMD-2 and two for HMD-3). The sequences of transgenes derived from the 
HNI genome was distinguished by SNPs within the regions between Hd-rR and HNI in 
these experiments as shown in Fig. 3-2. However, I was unable to distinguish 
Hd-rR-derived transgenes from d-rR host genome sequences because of high similarity 
between Hd-rR and d-rR and thus the results were presented as a mixture of endogenous 
and introduced sequences. In this case, the methylation status of endogenous sequences 
was deduced if data are available in a transgenic line having its HNI counterpart (for 
example, see HMD-1 in Fig. 3-3). 
I originally thought that the methylation status in transgenes follows their 
original one, i.e. if a methylated fragment in a donor species is introduced into the d-rR 
host genome, it would regain the methylated status in descendant embryos. 
Unexpectedly, however, this was not the case; all injected genomic fragments were 
found to remain hypomethylated irrespective of their original methylation status. In 
some cases, methylation was detected in introduced fragments but it was very limited 
(for example, see Fig. 3-3, HMD-2, HNI type (introduced) in HNI-type introduced fish). 
Regarding the HNI specific HMD (Fig. 3-3), the sequences from two HNI specific 
HMDs were almost hypomethylated in two lines in which HNI specific HMDs were 
introduced (Fig. 3-3, right, HMD-1 and HMD-2, HNI type (introduced) in HNI 
type-introduced fish), and their counterpart endogenous sequences in the host 
recapitulated the same pattern as Hd-rR, i.e. methylated (Fig. 3-3, right, HMD-1 and 
HMD-2, Hd-rR type (endogenous) in HNI type-introduced fish). On the other hand, in 
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the fish which have the methylated counterparts of HNI specific HMDs (their 
corresponding sequences of Hd-rR which are highly methylated in vivo), both mostly 
hypomethylated reads and mostly methylated reads were obtained (Fig. 3-3, left, 
HMD-1, HMD-3, Hd-rR type-introduced fish). In these fish, although I was unable to 
distinguish the introduced Hd-rR sequences and endogenous d-rR sequences, I reasoned 
that the substantial hypomethylated reads were derived from the introduced sequences.  
I then examined the methylation pattern of introduced sequences of the 
common HMDs. I found that almost all introduced sequences exhibited the 
hypomethylated status (Fig. 3-4), although some CpGs were partially methylated in the 
fish to which the Hd-rR or HNI type sequence of HMD-3 was introduced (Fig. 3-4, 
HMD-3, Hd-rR-type introduced or HNI-type introduced fish).   
Since I failed to obtain any positive results of clearly DNA methylation in 
transgenes, I suspected that DNA methylation failed to occur even in originally 
methylated regions in both species. For this, I reexamined the methylated status of 
highly-methylated regions that reside within the introduced sequences and flank HMD 
in the transgenic lines of HNI-specific HMD-1 and HMD-2 (Fig. 3-3) and common 
HMD-1 and HMD-2 (Fig. 3-4). As a result, the methylation was none or only partial at 
all the introduced HNI sequences, while its endogenous sites were highly methylated 
(Fig. 3-5).  
 
The partial methylation of the transgenes is observed in other transgenic medaka 
and differentiated cells 
 The failure of DNA methylation in introduced sequences could be due to the 
short period that passed after integration. Indeed, I examined only F1 or F2 embryos. To 
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test this idea, I examined whether the observed tendency was applicable to transgenic 
fish that passed many generations after establishment. I chose one transgenic medaka 
fish which were established previously and had been maintained in my laboratory. This 
transgenic line carries the BAC construct including zic1/4 genes (referred to as zicTg) 
(Kawanishi et al., 2013). I performed the bisulfite analysis targeting blastula–stage 
embryos of this transgenic fish and successfully amplified three regions that are known 
to be highly methylated in the original genome of d-rR background. First, I confirmed 
that all reads were mostly methylated in two of these regions derived from the host d-rR 
genome at the blastula stage (Fig. 3-6, lower). For the transgenes, although the results 
were again presented as a mixture of endogenous and transgenic fragments due to their 
nearly identical sequences (Fig. 3-6, upper), while deduced endogenous sequences were 
highly methylated, a substantial number of the fragments remained hypomethylated.  
To examine the observed partial methylation in the introduced genes were only 
seen in blastula cells, I examined the methylation pattern in the differentiated cells. As 
differentiated cells, I chose liver cells since liver has a substantial size and easy to 
extract from body of adult fish. I extracted genomic DNA from liver of my transgenic 
fish (two lines) and zicTg respectively, and performed bisulfite analysis for these three 
lines at the same five regions with Fig. 3-5 (HNI specific HMD-1, HNI specific HMD-2 
left and right) and Fig. 3-6 (Region A and Region C). As shown in Fig. 3-7, among the 
three regions which I investigated, one exhibited relatively hypomethylated status in the 
endogenous site in adult liver (HMD-2 left, Hd-rR type), the other two regions remained 
highly-methylated in the endogenous sites in adult liver (HMD-1 and HMD-2 right, 
Hd-rR type). However, the methylated status was still incomplete in these introduced 
sequences (HMD-1 and HMD-2 right, HNI type). This incomplete methylation in the 
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introduced sequences was also confirmed in liver cells of adult fish of zicTg (Fig. 3-8). 
These results suggest that methylation occur only partial even in differentiated cells. 
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Discussion 
In this chapter, in order to examine whether the differences in DNA 
methylation pattern seen in the identified species-specific HMDs are caused by intrinsic 
genomic sequence differences, I made transgenic medaka carrying HMD or methylated 
sequences, then performed the bisulfite analysis with F1 or F2 embryos of these lines. 
However, unexpectedly, I found that at the blastula stage, DNA methylation did not 
occur or partially, if any, in all the introduced sequences, irrespective of their original 
methylation status (Fig. 3-2, 3-3, 3-4). Furthermore, even in the HMD-flanking 
sequences of which the original sites are highly methylated in vivo in both species (Fig. 
3-5), DNA methylation was limited. This lack of DNA methylation could be a general 
phenomenon for exogenously introduced DNA sequences, because the same result was 
obtained with the blastula cells of transgenic line (zicTg) which was established long 
time ago in my laboratory (Fig. 3-6) and with other cells (liver cells) of my transgenic 
fish and zicTg (Fig. 3-7,  3-8). This is a sharp contrast with previous results with 
mouse stem cells (Lienert et al., 2011). Given that DNA fragments to be injected were 
methylation-free during preparation of DNA constructs, my present results imply that de 
novo methylation fails to target exogenous DNA fragments in medaka.  
Why do introduced DNA fragments maintain the hypomethylated status in 
vivo? One possibility is that the exogenous sequence included in the constructs (β
-actin promoter and GFP) may affect DNA methylation status of nearby regions. 
Another possibility would be that exogenous DNAs, once introduced, are marked by 
some unknown tags, which specifically protect them from de novo methylation. 
Integration sites could also affect the efficiency of de novo methylation.  
The lack of or limited global demethylation in fish may need to be considered 
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in interpreting my present results. As described in Introduction, during early 
embryogenesis, mammals are known to experience global demethylation and the 
subsequent de novo methylation (for review, see Wu and Zhang, 2010). In contrast, in 
some organisms, the absence of global demethylation process has been suggested 
(Macleod et al., 1999; Veenstra and Wolffe, 2001). This is also the case for medaka 
(Walter et al., 2002). Although dynamics of DNA methylation still remains largely 
elusive in medaka, recent studies in zebrafish showed that the methylation pattern of 
sperm is inherited to embryonic cells, while the oocyte methylome is reprogrammed to 
a pattern similar to that of sperm after fertilization (Jiang et al., 2013; Potok et al., 2013). 
Like zebrafish, the methylation status of medaka blastula cells seems highly similar to 
that of sperm (at least as for HMDs, > 95% of each stage’s HMDs was commonly seen 
between blastula cells and sperm in my analysis), suggesting that medaka adopts the 
zebrafish-type methylation process, rather than mammalian-type. There is a possibility 
that such fundamental difference may be related to the difference in DNA methylation 
to exogenous sequences between medaka and mammals in part, but at the moment I do 
not have evidence which discriminates these possibilities and it still remains to be 
addressed. 
It is, however, worth noting that DNA methylation seemed to occur at some sites, in a 
part of my transgenic fish (For example, see HNI–type reads (right) in Fig. 3-2). Thus, 
in spite of relatively loose methylation situation in medaka, the wave of de novo 
methylation seems to exist. Under such situation, the conservation and enrichment of 
the identified 6-mer could contribute to HMD formation and/or maintenance. Anyway, 
further studies will be required to elucidate the factors that cause the difference in 
methylation pattern seen in transgenes between mammals and medaka. 
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General Discussion 
 In my doctoral thesis, I compared DNA hypomethylated domains (HMDs) in 
the two medaka inbred lines, Hd-rR and HNI, which are established from the two 
closely related species, Oryzias latipes and Oryzias sakaizumii, respectively. I 
demonstrated that the majority of HMDs in blastula cells are shared by Hd-rR and HNI, 
but that a small portion of HMDs only exist in one species (species-specific HMDs). 
Genes in or nearby species-specific HMDs tend to show species-specific expression 
levels and thus are expected to contribute to the species-specific characters in these 
medaka species (Ishikawa et al., 1999; Kimura et al., 2007; Tsuboko et al., 2014). The 
studies identifying the differentially methylated regions in inbred lines or closely related 
species have been very limited, probably due to the lack of high quality genome and 
genome-wide base-resolution methylomes. In this context, these species-specific HMDs 
identified in medaka in my study may be interesting targets for the future research of 
DNA methylation-based phenotypic differences.  
 Hd-rR and HNI are known to show high incidence of genetic variations 
(Kasahara et al., 2007). This was confirmed in my study, and furthermore, I revealed 
that even HMDs shared by the two species accumulate genetic variations at similar rates 
to other methylated regions. At first glance, this finding was curious but my subsequent 
analysis identified some short sequences which are highly conserved in HMDs under 
such high genetic variations. Furthermore, I found that some of the highly-conserved 
6-mers (showing low mutation index rate (common / Hd-rR specific)) reside in the 
nucleosome linker region within HMDs. The downstream region of TSSs is known to 
have highly-phased nucleosome arrays, but the mechanism of nucleosome positioning is 
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still controversial. The dependence of positioning on the intrinsic sequences varies 
among organisms. In this context, my results in Chapter 2 should support the existence 
of a DNA-guided mechanism in medaka, in that these identified motifs are suggested to 
function in nucleosome positioning. Notably, previous studies demonstrated that the 
nucleosome core is known to disfavor AT-rich sequences such as poly (dA:dT), but in 
my study, such bias was not observed in these motifs’ base composition. Furthermore, 
although these sequences showed no similarity to binding motifs of known TFs, most of 
them are suggested to function as motif. Therefore, they may compose an intrinsically 
disfavorable structure for nucleosome core positioning, or serve as unknown binding 
sites of TFs, thereby positioning nucleosome core stably in specific regions. Future 
studies focusing on these motifs will give us further novel insights into the mechanism 
of nucleosome positioning.  
 In Chapter 3, I made transgenic medaka carrying HMD sequences and found 
that DNA methylation failed to target introduced DNA fragments in medaka irrespective 
of the methylation status of its endogenous site. This revealed a clear difference from a 
previous report using mouse stem cells. However, my data are still limited at present 
and further studies are required to discuss de novo methylation in medaka. 
 Through my doctoral thesis, the medaka system was further recognized as a 
very attractive model for epigenetic research. Medaka has a big advantage such as the 
established inbred lines and high-quality draft genomes. As described above, the 
comparison of DNA methylation patterns and genomic sequences between the two 
medaka inbred lines and the subsequent analyses in my study provided novel insights 
and interesting targets for future study. More than 10 inbred lines of medaka are 
currently maintained in Japan, including one from the Korean medaka (HSOK), and 
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efforts are being made to create additional strains from different regional populations, 
including close relatives (Takeda and Shimada, 2010). Although the resource in 
genomes and epigenetic modifications is not sufficient for other inbred lines for now, 
their comparative analysis will give us further insights into how genomic sequences are 
interpreted as the epigenetic code, and how such changes lead to changes in phenotypes. 
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Material and Methods 
Fish strains 
I used medaka Hd-rRII1 (referred to as Hd-rR), d-rR, and HNI-II (referred to as 
HNI). Medaka fishes were maintained and raised under standard condition. All 
experimental procedures and animal care were carried out according to the animal ethics 
committee of the University of Tokyo. 
 
Identification of common HMDs and species-specific HMDs  
First, I mapped the bisulfite-treated reads collected from of HNI blastula-stage 
embryos (Qu et al., 2012) to the HNI genome (version 2) which became available 
recently (http://mlab.cb.k.u-tokyo.ac.jp/~yoshimura/Medaka/#!Assembly.md), 
according to the mapping condition previously described (Qu et al., 2012). Then, based 
on the same criteria as the previous report from my laboratory (Nakamura et al., 2014), I 
identified the region containing at least 10 continuous low-methylated (methylation rate 
< 0.4) CpGs as HMDs in HNI blastula embryos.  
Next, I mapped the identified HMD sequences of each species to the genome 
of the other species using BLAT (tileSize=18, oneOff=1) (Kent, 2002), as the mapping 
with such parameters are compatible with both high sensitivity (> 99.9% are expected, 
data not shown) and short calculation time. Among the outputs, due to partial 
similarities, queries were sometimes mapped to much longer genomic regions. A 
majority of such cases seemed mapping errors, because insertion or deletion events of > 
2 kb regions were rare in the regions which were reliably aligned between the two 
species. Thus, in order to obtain reliable comparison, I did not include the outputs for 
further analysis in which the mapped region’s length is > 2 kb longer than that of query 
47 
 
HMD. After removing these outputs, I further isolated query sequences 
(hypomethylated sequences in Hd-rR or HNI) which were uniquely mapped or multiply 
mapped to other genomic regions. I set a criterion that 80% of query’s sequences were 
aligned in the other species’ genome. This criterion excluded 1% (Hd-rR mapped to 
HNI) or 4% (HNI to Hd-rR) of uniquely mapped pairs and 92% (both cases) of multiple 
mapped pairs. To further isolate reliable pairs from the remaining multiply mapped 
outputs, I extracted pair as reliable ones of which the best matching rate of such pair 
(the ratio of the number of the base matches to the whole query size) was > 50% higher 
than that of any other pairing.  
 Subsequently, from the remaining results, I selected those in which the 
mapped genomic region of the query HMD was unique and was not covered by any 
other query HMDs. Last, I extracted the mapping results in which the query HMD was 
anchored to the same chromosome. 
Next, with the remaining results, I checked if each HMD of the target genome 
overlapped with the mapped region of the query HMD. If the test was negative, I 
regarded that such an HMD had no corresponding HMD in the other species and 
identified it as a ‘species-specific HMD’; otherwise, I treated it as a ‘common HMD’ 
that is shared in common in both species. Since > 94% of the common HMDs which 
were identified from the mapping of Hd-rR HMDs to HNI genome overlapped with the 
common HMDs which were identified from the mapping of HNI HMDs to Hd-rR 
genome, I used the former set as ‘common HMDs’ in all analyses. 
 
RNA-seq 
For d-rR blastula cells, the previously obtained data was used (Nakatani et al., 
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2015). For HNI blastula cells, RNA was isolated using ISOGEN (Nippon Gene) and 
RNeasy mini kit (QIAGEN) and treated with Ribominus eukaryote kit for RNA-seq 
(Life Technologies). RNA-seq library was prepared using TruSeq RNA-seq sample 
prep kit (Illumina). The PCR products were purified and size fractionated using a 
bead-mediated method (AMPure, Ambion). Sequencing was conducted on HiSeq 2500 
platform (Illumina). Sequences were mapped using BWA (Burrows-Wheeler Alignment 
tool) (Li and Durbin, 2009) and RPKM (reads per kilobase of exon per million mapped 
reads) was calculated using SAMMATE software (Xu et al., 2011). 
 
Calculation of the incidence of genetic variations between Hd-rR and HNI 
I categorized the HMD sequences into three HMD groups, ‘common HMDs’, 
‘Hd-rR specific HMDs’ and ‘HNI specific HMDs’ and similarly classified the 
corresponding regions on the other species’ genome, and performed the alignment of 
reciprocally best matching pairs of sequences with LASTZ (Harris, 2007) 
(--format=axt) for each group. As the LASTZ sometimes produced multiple outputs 
with different size for the same region or outputs that partially overlapped with each 
other, I removed the relatively short outputs such that the whole aligned region of the 
query was covered by the longest or second-longest alignments for the same query, then 
extracted the alignments that were independent and did not overlap with each other. The 
sequences of gene exons were also excluded from the further analyses. Then, from the 
remaining output alignments, I counted the single nucleotide polymorphisms (SNPs), 
insertions and deletions. As a small portion of the mapped regions of common HMDs 
was methylated in HNI genome (~ 10% of all mapped regions), I excluded such 
methylated regions from further analysis of common HMDs. When the alignment of 
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one HMD was separated into more than one block, the mutations of the separated 
alignments were summed. Then, the mutation rate for each HMD was calculated by 
dividing the total number of mutations by the length (bp) of the investigated region. For 
the negative control data set, the original Hd-rR HMD genome-coordinate set was 
randomly distributed on methylated regions using bedtools (ver. 2.17.0) (Quinlan and 
Hall, 2010). Then, the obtained sequences of the methylated regions were treated as 
well as HMDs and used for the calculation of the incidence of genetic variations.  
 
Calculation of 6-mer’s mutation index  
Using the output of LASTZ alignment, I examined whether a 6-mer is mutated 
or not by searching the query and the aligned regions for the 6-mer. To take into account 
the case that short indels occur within a 6 bp aligned region, but 6-mer is still conserved 
between two medaka genomes in spite of such indels, I extracted the aligned regions 
flanked by the 8 bp with no-mismatch, and examined whether the 6-mer is conserved 
within the extracted regions. If the 6-mer in the query was not found in the aligned 
region, the 6-mer was regarded as ‘mutated’. Then, the mutation index was calculated 
by dividing the number of ‘mutated’ 6-mers by the total number of the 6-mers in the 
query. The calculation results of the motif and its reverse complement were combined 
for each 6-mer.  
 
Motif analyses 
TOMTOM (Gupta et al., 2007) was used to search motifs similar to top 20 
selected 6-mers. JASPAR Vertebrates and UniPROBE Mouse databases were used as 
target motifs. I set the significance threshold (q value < 0.1) in the selection of outputs. 
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Making transgenic medaka 
For each three selected HMDs from each set of HMDs (common HMDs, 
Hd-rR specific HMD and HNI specific HMDs), I cloned the sequence of each HMD 
and its flanking region (~ 2 kb length from both HMD boundaries) from the genomic 
DNA of Hd-rR adult liver or HNI adult liver with Phusion (NEW ENGRAND BioLabs). 
Then, I made the constructed in which each cloned sequence is preceded by β-actin 
promoter and followed by GFP coding sequence and flanked by I-SceI sites as shown in 
Fig. 3-1, with InFusion kit (Clontech). All the sequences of HMD and its flanking 
regions of the constructs were confirmed by sequencing. All primers for making 
constructs and sequence confirmation were listed on Table 5 and Table 6. 
I injected these constructs to d-rR embryos at 1-cell stage with I-SceI, and 
selected and raised the injected embryos with GFP-positive cells. I crossed each fish 
with d-rR adult fish and isolated and GFP-positive offspring, then raised them as F1 
fish.  
 
Bisulfite analysis of transgenic medaka 
For most lines, I crossed F1 adult male fish and F1 adult female fish and 
extracted genomic DNA from about 30 - 100 offspring at blastula stage. For 1 line (Fig. 
3-4, HMD-1), I extracted genomic DNA from F1 blastula embryos instead of F2 
embryos for further procedures. I performed bisulfite treatment of the extracted 
genomic DNA using MethylEasy Xceed Kit (Human Genetic Signatures). 
Bisulfite-converted DNA was subjected to PCR using Ex Taq (TaKaRa) and TOPO-TA 
cloning (life technologies). Amplified fragments were sequenced and analyzed and 
visualized by the QUMA software (Kumaki et al., 2008). All primers for PCR with 
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bisulfite-converted DNA were listed on Table 7. 
 For analysis of liver cells, I extracted genomic DNA from liver of 3 - 4 F2 
adult fish and performed bisulfite analysis and PCR as described above.   
 
Methylation patterns of liver cells of Hd-rR and HNI adult fish 
As well as blastula embryos, I mapped the bisulfite-treated reads collected 
from of liver cells of Hd-rR and HNI (Qu et al., 2012) to Hd-rR genome 
(http://www.ensembl.org) and the HNI genome (version 2) which became available 
recently (http://mlab.cb.k.u-tokyo.ac.jp/~yoshimura/Medaka/#!Assembly.md), 
respectively, according to the mapping condition previously described (Qu et al., 2012).  
 
Statistical analysis and the data visualization 
The statistical analysis and graph visualization were performed using R 
software (version 3.2.0). For the visualization of genome-wide data, we integrated the 
data into UTGB genome browser (Saito et al., 2009). 
 
Data access 
All sequence data are deposited at the NCBI Sequence Read Archive (SRA) 
(http://www.ncbi.nlm.nih.gov/sra) (accession number SRP070096). 
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Figures and Tables 
 
 
Figure 1-1. Identification of common HMD and species-specific HMD 
A. Schematic representation of HMDs in aligned genomic regions. Hd-rR blastula 
HMDs were mapped to the genome of HNI to identify common HMDs and 
Hd-rR specific HMDs. I also performed the mapping of HNI HMDs to Hd-rR 
genome for identifying HNI specific HMDs (not shown). Each picture shows male 
Hd-rR (upper) or HNI (lower) adult fish. 
B. Genome browser view showing the example of common HMDs, Hd-rR specific 
HMDs and HNI specific HMDs. The distribution of CpG is shown in black vertical 
lines and the methylation level is shown in orange ones. Black horizontal bars 
indicate the position of each HMD. The sequences of each HMD and its 2 kb 
flanking regions were mapped to the other species’ genome, and the 
methylation status of the two species was compared in aligned regions 
(red-dotted boxes). 
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Figure 1-2. Proportion of common HMDs and species-specific HMDs 
Venn diagram showing the overlap of HMDs between Hd-rR and HNI. Each 
picture above the diagram shows male Hd-rR or HNI adult fish. 
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Figure 1-3. The size of each HMD 
Boxplots showing the length of each HMD in common HMDs, Hd-rR specific 
HMDs and HNI specific HMDs. P-values were calculated using Wilcoxon rank 
sum test. In the box plots, the bottom and top of the boxes correspond to the 
25th and 75th percentiles; the internal band is the 50th percentile (median). The 
plot whiskers extending outside the boxes correspond to the lowest and highest 
datum within 1.5 interquartile ranges of the lower and upper quartiles, 
respectively. 
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Figure 1-4. The positions of each HMD sets 
Pie charts showing the proportion of HMD type (promoter (orange), gene body 
(green) and others (gray)) in common HMDs (left), Hd-rR specific HMDs (middle) 
and HNI specific HMDs (right). For categories, see text. 
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Figure 1-5. Relative expression level of the genes marked by HMDs 
Boxplots showing the ratio of RPKM of d-rR to HNI (d-rR / HNI) of the genes 
marked by common HMDs (green), Hd-rR specific HMDs (pink) and HNI-specific 
HMDs (blue). Genes were classified according to the position marked by HMDs, 
promoters (left), gene bodies (middle) and intergenic regions (right). In the 
calculation of the ratio of RPKM, the genes in which RPKM of the either species is 
0 are excluded. P-values were calculated using Wilcoxon rank sum test. In the 
box plots, the bottom and top of the boxes correspond to the 25th and 75th 
percentiles; the internal band is the 50th percentile (median). The plot whiskers 
extending outside the boxes correspond to the lowest and highest datum within 
1.5 interquartile ranges of the lower and upper quartiles, respectively. 
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Figure 1-6. Genetic variations between Hd-rR and HNI in HMDs 
Boxplots showing the incidence of genetic variations between Hd-rR and HNI. 
The left figure shows the rate of single nucleotide polymorphisms (SNPs) per 
base pair, and the right one shows the rate of insertions and deletions per base 
pair in the methylated regions (gray), common HMDs (green), Hd-rR specific 
HMDs (pink) and HNI specific HMDs (blue). Note that exons in the Hd-rR 
genome and their aligned regions in HNI genome were excluded in this analysis, 
because the proportions of those regions could vary among the investigated 
HMD set. P-values were calculated using Wilcoxon rank sum test. In the box 
plots, the bottom and top of the boxes correspond to the 25th and 75th 
percentiles; the internal band is the 50th percentile (median). The plot whiskers 
extending outside the boxes correspond to the lowest and highest datum within 
1.5 interquartile ranges of the lower and upper quartiles, respectively. 
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Figure 1-7. Identification of the conserved sequences within common 
HMDs 
A. An example of calculation of mutation index. The target 6-mer TTATGG is 
found at four regions in the upper sequences of aligned sequences and is 
mutated at one of them (blue), so mutation index of TTATGG is 0.25 in this 
region. 
B. Histograms showing the distributions of the ratio of mutation index (common 
HMDs / Hd-rR specific HMDs) for 6-mers with CpGs (left) and without CpGs 
(right).  
C. Lists of top 20 most conserved 6-mers with CpGs (left) and without CpGs 
(right), which have the lowest values in the ratio of mutation index (common 
HMDs / Hd-rR specific HMDs). 
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Figure 1-8. Enrichment levels of the conserved sequences within common 
HMDs 
A. Boxplots showing the 6-mer’s enrichment levels in common HMDs (the ratio 
of each 6-mer’s frequency (common HMDs / methylated regions)).  
B. Boxplots showing the 6-mer’s enrichment levels in common HMDs (the ratio 
of each 6-mer’s frequency (common HMDs / species-specific HMDs)).  
Gray boxes represent the all 6-mers, while orange and purple boxes represent 
the top 20 most conserved 6-mers with and without CpGs, respectively. P-values 
were calculated using Wilcoxon rank sum test. In the box plots, the bottom and 
top of the boxes correspond to the 25th and 75th percentiles; the internal band 
is the 50th percentile (median). The plot whiskers extending outside the boxes 
correspond to the lowest and highest datum within 1.5 interquartile ranges of 
the lower and upper quartiles, respectively. 
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Figure 1-9. Distribution of the conserved sequences around HMD boundary 
Distribution pattern of the top 20 most conserved 6-mers with CpGs (orange) or 
without CpGs (purple) in the 2 kb region around the boundary of the HMDs of 
which the size is > 2 kb. The boundaries of HMD were defined at the first 
low-methylated CpG site inside the HMD. X axis shows the length of each 
position from the HMD boundary. Downstream regions are hypomethylated. 
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Figure 1-10. Schematic representation of conserved DNA motifs and 
genetic variations in common HMDs and the methylated regions 
In common HMDs, specific DNA motifs (yellow rectangles) are conserved under 
high incidence of genetic variations (red stars). These motifs are enriched in 
common HMDs compared to methylated regions. 
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Figure 2-1. Basic principle of DNase-seq technique to reveal accessible 
chromatin 
DNase I can digest accessible DNA which is depleted from nucleosome, thereby 
releasing DNA fragments. The high-throughput sequencing of them and the 
subsequent mapping of the reads to the genome can reveal accessible 
chromatin regions genome-wide. 
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Figure 2-2. The distribution profile of DNase-seq signals around each 
selected top 20 6-mers with CpGs or without CpGs 
The Upper two graphs show the average distribution profile of DNase-seq signal 
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around selected top 20 with CpGs (left) and without CpGs (right). The other 
graphs show distribution profile of DNase-seq signal around each 6-mer. Red 
and black line of each graph shows the signal within HMDs and outside HMDs, 
respectively. For categories, see text. 
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Figure 2-3. Nucleosome core positioning score and DNase-seq signal 
around the selected 6-mers with strong or intermediate periodicity of 
DNase-seq signal 
The distributions of nucleosome core positioning score within HMDs (blue) or 
without HMDs (gray) and DNase-seq signal within HMDs (red) or without HMDs 
(black) around the selected 6-mers with strong or intermediate periodicity. For 
details, see text. 
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Figure 2-4. Nucleosome core positioning score around the selected 6-mer 
with strong periodicity of DNase-seq signal or its reverse 6-mer within 
HMDs 
Blue line shows the 6-mer with periodicity and green line shows its reverse 6-mer. 
Reverse 6-mers, except for the case of CGCTAG, do not have periodic 
nucleosome core positioning score in their neighboring regions. For details, see 
text. 
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Figure 3-1. The overview of the experiment of bisulfite analysis with 
transgenic medaka 
The constructs carrying HMD-sequence and its flanking regions were injected to 
d-rR 1 cell-stage embryos, and then GFP positive embryos were raised as F0. 
Adult F0 was crossed with d-rR, then, among the obtained embryos GFP positive 
embryos were raised as F1. The genomic DNA was extracted from F1 embryos or 
the offspring of F1 parents (F2 embryos) at blastula-stage and DNA methylation 
patterns of them were analyzed by bisulfite conversion and PCR.  
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Figure 3-2. Bisulfite sequencing in F2 blastula embryos of transgenic 
medaka to which HNI-type sequence (methylated) of Hd-rR specific HMD is 
introduced 
The upper figure is genome browser image showing the methylation pattern of 
blastula embryos of Hd-rR and HNI around the HMD. The sequence of the HMD 
and its 2 kb flanking regions was mapped to the other species’ genome, and the 
methylation status of the two species was compared in aligned regions. The 
distribution of CpG is shown in black vertical lines and the methylation levels are 
shown in orange ones. A blue-dotted box shows the introduced region to the 
transgenic fish and a black horizontal bar shows the position of the amplified 
region from bisulfite-converted genomic DNA. In lower two figures, the positions 
of circle indicate the positions of CpG in each read. Unmethylated CpGs are 
shown as white circles and methylated CpGs are shown as black circles. The short 
sequences above each methylation patterns show an example of SNP between 
Hd-rR and HNI seen in the region. 
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Figure 3-3. Bisulfite sequencing in F2 blastula embryos of transgenic 
medaka to which Hd-rR-type sequence (methylated) or HNI-type sequence 
(hypomethylated) of HNI specific HMD is introduced 
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Genome browser images show the methylation pattern of blastula embryos of 
Hd-rR and HNI around each HMD. The sequences of each HMD and its 2 kb 
flanking regions were mapped to the other species’ genome, and the 
methylation status of the two species was compared in aligned regions. The 
distribution of CpG is shown in black vertical lines and the methylation levels are 
shown in orange ones. Red-dotted or blue-dotted boxes show the introduced 
region to the transgenic fish and black horizontal bars show the positions of the 
amplified regions from bisulfite-converted genomic DNA. The figures below 
each genome browser image show methylation status of the amplified regions. 
The positions of circle indicate the positions of CpG in each read. Unmethylated 
CpGs are shown as white circles and methylated CpGs are shown as black circles. 
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Figure 3-4. Bisulfite sequencing in F1 or F2 blastula embryos of transgenic 
medaka to which Hd-rR-type sequence (hypomethylated) or HNI-type 
sequence (hypomethylated) of common HMD is introduced 
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Genome browser images show the methylation pattern of blastula embryos of 
Hd-rR and HNI around each HMD. The sequences of each HMD and its 2 kb 
flanking regions were mapped to the other species’ genome, and the 
methylation status of the two species was compared in aligned regions. The 
distribution of CpG is shown in black vertical lines and the methylation levels are 
shown in orange ones. Red-dotted or blue-dotted boxes show the introduced 
region to the transgenic fish and black horizontal bars show the positions of the 
amplified regions from bisulfite-converted genomic DNA. The figures below 
each genome browser image show methylation status of the amplified regions. 
The positions of circle indicate the positions of CpG in each read. Unmethylated 
CpGs are shown as white circles and methylated CpGs are shown as black circles. 
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Figure 3-5. Bisulfite sequencing at HMD-flanking regions in F1 or F2 
blastula embryos of transgenic medaka to which HNI-type sequence 
(hypomethylated) of HNI specific HMD or common HMD is introduced 
Genome browser images show the methylation pattern of blastula embryos of 
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Hd-rR and HNI around each HMD. The sequences of each HMD and its 2 kb 
flanking regions were mapped to the other species’ genome, and the 
methylation status of the two species was compared in aligned regions. The 
distribution of CpG is shown in black vertical lines and the methylation levels are 
shown in orange ones. Blue-dotted boxes show the introduced region to the 
transgenic fish and black horizontal bars show the positions of the amplified 
regions from bisulfite-converted genomic DNA. The figures below each genome 
browser image show methylation status of the amplified regions. The positions 
of circle indicate the positions of CpG in each read. Unmethylated CpGs are 
shown as white circles and methylated CpGs are shown as black circles. 
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Figure 3-6. Bisulfite sequencing at methylated regions in blastula embryos 
of zicTg 
Genome browser images show the methylation pattern of blastula embryos of 
Hd-rR around zic1/4 genes. The distribution of CpG is shown in black vertical 
lines and the methylation levels are shown in orange ones. Black horizontal bars 
show the positions of the amplified regions from bisulfite-converted genomic 
DNA. The two magnified genome browser images show the same regions with 
those within red or blue-dotted boxes in the top image. The figures below the 
genome browser image show methylation status of the amplified regions. The 
positions of circle indicate the positions of CpG in each read. Unmethylated CpGs 
are shown as white circles and methylated CpGs are shown as black circles. 
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Figure 3-7. Bisulfite sequencing at HMD-flanking regions in liver cells of F2 
transgenic medaka to which HNI-type sequence (hypomethylated) of HNI 
specific HMD is introduced 
Genome browser images show the methylation pattern of blastula embryos and 
liver cells in Hd-rR and HNI around each HMD. The sequences of each HMD and 
its 2 kb flanking regions were mapped to the other species’ genome, and the 
methylation status of the two species was compared in aligned regions. The 
distribution of CpG is shown in black vertical lines and the methylation levels are 
shown in orange ones. Blue-dotted boxes show the introduced region to the 
transgenic fish and black horizontal bars show the positions of the amplified 
regions from bisulfite-converted genomic DNA. The figures below each genome 
browser image show methylation status of the amplified regions. The positions 
of circle indicate the positions of CpG in each read. Unmethylated CpGs are 
shown as white circles and methylated CpGs are shown as black circles. 
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Figure 3-8. Bisulfite sequencing at methylated regions in liver cells of zicTg 
Genome browser images show the methylation pattern of blastula embryos and 
liver cells in Hd-rR around zic1/4 genes. The distribution of CpG is shown in black 
vertical lines and the methylation levels are shown in orange ones. Black 
horizontal bars show the positions of the amplified regions from 
bisulfite-converted genomic DNA. The two magnified genome browser images 
show the same regions with those within red or blue-dotted boxes in the top 
image. The figures below the genome browser image show methylation status of 
the amplified regions. The positions of circle indicate the positions of CpG in 
each read. Unmethylated CpGs are shown as white circles and methylated CpGs 
are shown as black circles. 
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Supplementary Figure S1. Genome browser view of the DNA methylation 
and DNase-seq signals.  
The distribution of CpG is shown in black vertical lines, the methylation level is 
shown in orange ones and DNase-seq signal is shown in black. DNase-seq signal 
within the HMD shows the periodic pattern of peaks of approximately 200 bp 
intervals. 
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Table 1. RPKM of the genes which have Hd-rR specific HMDs in their 
promoters.  
Gene ID Gene name RPKM in d-rR RPKM in HNI
ENSORLG00000000045 NoName 8.0407 4.6834
ENSORLG00000000081 ptp4a1 359.0151 257.4057
ENSORLG00000000213 ARPC2(1of2) 0.5345 0.0000
ENSORLG00000000293 si:ch211-255i20.3 0.2021 0.7691
ENSORLG00000000313 lygl1 1.3207 0.0000
ENSORLG00000000335 slit3 1.0544 0.6687
ENSORLG00000000509 ptgs1(1of2) 0.8027 0.6108
ENSORLG00000000640 ints4 12.5449 14.8229
ENSORLG00000000741 NoName 1.7088 0.2167
ENSORLG00000000754 RHBDF2 36.4830 27.3777
ENSORLG00000000833 dus2 31.7360 50.7089
ENSORLG00000001169 NoName 4873.4900 728.2306
ENSORLG00000001183 si:ch73-56p18.4 20.3897 20.5034
ENSORLG00000001307 NoName 0.0000 1.2257
ENSORLG00000001585 mfsd10 51.5743 43.0059
ENSORLG00000001627 pcsk9 0.3819 1.0897
ENSORLG00000001697 KIF2A(1of2) 1.3342 5.0763
ENSORLG00000001769 slc30a8 33.6519 6.0972
ENSORLG00000001776 NoName 0.0000 0.0000
ENSORLG00000001861 pard6b 9.3640 20.8220
ENSORLG00000001880 dpm1 20.4857 30.2149
ENSORLG00000002073 slc22a15 11.9408 14.3375
ENSORLG00000002252 myt1b 1.8694 5.1026
ENSORLG00000002339 slc1a8a 8.8715 6.0684
ENSORLG00000002460 CLINT1(1of2) 13.4532 11.8540
ENSORLG00000002526 fermt3b 1.5570 0.8078
ENSORLG00000002622 ldb3a 0.1239 0.0000
ENSORLG00000002741 lrrc34 1.1900 0.6174
ENSORLG00000002748 TXK 0.3370 0.4274
ENSORLG00000002764 si:dkeyp-86f7.4 123.0693 132.9525
ENSORLG00000002766 sept4a 0.8262 0.0000
ENSORLG00000002806 ttc9c 4.1224 5.3778
ENSORLG00000003248 si:dkey-7e14.3 0.9927 2.8329
ENSORLG00000003303 SEPT9(1of2) 23.4424 53.9376
ENSORLG00000003649 NoName 0.1338 0.0000
ENSORLG00000003726 stard13a 0.4812 0.0000
ENSORLG00000003819 atic 59.2824 75.6765
ENSORLG00000003841 cabp2b 0.0000 0.0000
ENSORLG00000003911 taf2 13.4743 20.1411
ENSORLG00000003959 HRH2(1of2) 0.6422 1.2217
ENSORLG00000004413 gckr 0.3343 0.6360
ENSORLG00000004424 asph 20.7803 21.4418
ENSORLG00000004792 adgrl3.1 0.5426 0.1214
ENSORLG00000004819 dhx15 63.3069 68.5875
ENSORLG00000004845 PAXBP1 56.0877 50.0914
ENSORLG00000005181 slc27a2b 7.8703 26.0275
ENSORLG00000005308 lim2.3 0.5365 0.0000
ENSORLG00000005381 lrp2b 0.3798 0.0619
ENSORLG00000005557 NoName 0.7960 1.0096
ENSORLG00000005581 NoName 0.4811 1.8305
ENSORLG00000005592 rps15 409.4277 160.3491
ENSORLG00000005630 mcf2la 6.2056 22.2997
ENSORLG00000005961 NoName 155.9052 1.1161
ENSORLG00000005964 cldnd1a 9.2129 9.4646
ENSORLG00000005993 oacyl 0.0000 0.0000
ENSORLG00000006157 slc17a6b 0.0816 0.0000
ENSORLG00000006195 si:ch73-67c22.3(14of37) 6.1828 4.3244
ENSORLG00000006223 si:dkey-185e18.6 3.4746 1.6525
ENSORLG00000006283 smu1b 1.1513 0.7301
ENSORLG00000006359 wu:fd14a01(4of6) 0.0989 0.1882
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Table 1 (continued) 
Gene ID Gene name RPKM in d-rR RPKM in HNI
ENSORLG00000006375 EGR4 0.9197 0.0000
ENSORLG00000006490 brd4 23.0851 32.0824
ENSORLG00000006833 cers5 6.3449 0.7100
ENSORLG00000006850 wnt8b 0.1333 0.0000
ENSORLG00000007124 bmp8a 0.8013 0.0000
ENSORLG00000007296 si:ch1073-280h16.1 28.4137 65.8713
ENSORLG00000007558 gcnt3 8.6037 0.3148
ENSORLG00000007631 rnf26 29.4956 28.7356
ENSORLG00000007789 march1 0.3581 0.0000
ENSORLG00000007861 rarga 14.6317 13.1855
ENSORLG00000007932 rcn2 49.5532 61.1183
ENSORLG00000008028 zgc:92360 0.2497 0.7125
ENSORLG00000008045 slc25a26 4.4875 3.4148
ENSORLG00000008114 SLCO5A1(3of3) 20.3409 21.0646
ENSORLG00000008204 tusc5a 0.0000 0.0000
ENSORLG00000008287 asb12b 0.1330 3.7962
ENSORLG00000008568 akr1a1a 4.1885 4.1653
ENSORLG00000008655 acsl1b 0.6878 0.0000
ENSORLG00000008718 NoName 0.0000 0.0000
ENSORLG00000008851 txlnbb 0.3233 0.4101
ENSORLG00000008978 TMEM233 1.9991 0.0000
ENSORLG00000008984 LMNA(1of2) 0.8929 0.3640
ENSORLG00000009025 kcnip3b 0.9319 0.0000
ENSORLG00000009162 kcnk12l 0.3508 0.0000
ENSORLG00000009204 acer1 6.4976 0.3341
ENSORLG00000009220 gorasp2 32.3853 18.3576
ENSORLG00000009491 NoName 0.2984 0.0000
ENSORLG00000009564 NoName 0.0000 0.0000
ENSORLG00000009585 GAB3 0.4103 0.1301
ENSORLG00000009853 NoName 60.8808 107.5492
ENSORLG00000010101 zgc:101785 10.8423 2.5087
ENSORLG00000010130 jmjd7 6.3679 9.8431
ENSORLG00000010131 chst2b 9.7510 0.0000
ENSORLG00000010188 NoName 6.5718 0.0000
ENSORLG00000010534 CYP46A1(2of2) 53.7104 0.0000
ENSORLG00000010738 FCHSD1 0.3510 0.1335
ENSORLG00000010811 trappc11 13.7378 26.4642
ENSORLG00000010872 vrk1 94.6376 60.1372
ENSORLG00000011003 EPHB1(1of2) 1.5064 1.1642
ENSORLG00000011018 NoName 24.5735 18.8639
ENSORLG00000011521 NoName 0.1645 0.0000
ENSORLG00000011646 RASA2 5.7228 15.4650
ENSORLG00000011676 NoName 1.0537 4.5102
ENSORLG00000011698 ddias 15.2902 7.2722
ENSORLG00000011703 NoName 5.5518 11.0648
ENSORLG00000011885 hdhd2 6.8434 12.1396
ENSORLG00000011950 NoName 15.4618 66.4322
ENSORLG00000012156 ano10b 6.0518 1.3116
ENSORLG00000012194 srd5a2b 0.3224 0.8178
ENSORLG00000012440 auts2a 0.3767 0.0896
ENSORLG00000012675 NoName 0.9816 1.2450
ENSORLG00000012838 bace2 13.6916 105.2484
ENSORLG00000012875 poll 24.2972 30.1093
ENSORLG00000013041 PTCHD3 0.1059 0.0000
ENSORLG00000013244 vmhcl 0.0000 0.2830
ENSORLG00000013368 lrrc53 0.2320 0.0000
ENSORLG00000013616 slc16a7 0.5559 0.1763
ENSORLG00000013691 parp1 130.2761 64.7385
ENSORLG00000013731 pkd2l1 1.4113 0.2685
ENSORLG00000013769 zgc:92107 68.5084 67.5954
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Table 1 (continued) 
Gene ID Gene name RPKM in d-rR RPKM in HNI
ENSORLG00000013831 APOH 0.0000 0.5752
ENSORLG00000013910 tnfrsf9a 12.5085 12.0707
ENSORLG00000013920 FADS6 0.4054 0.0000
ENSORLG00000013983 NoName 34.8152 10.7085
ENSORLG00000013993 keap1a 3.5495 20.5650
ENSORLG00000014020 NoName 34.8443 5.9070
ENSORLG00000014089 NOX5 0.3230 1.9664
ENSORLG00000014119 map3k1 0.3483 0.6626
ENSORLG00000014180 si:ch1073-416j23.1 41.0016 99.9458
ENSORLG00000014235 PPAP2C(1of2) 55.4012 88.6299
ENSORLG00000014287 kif3a(2of2) 0.0000 0.0000
ENSORLG00000014312 serpinh1b 2.0347 0.2150
ENSORLG00000014430 NoName 0.4261 0.0000
ENSORLG00000014608 adoa 36.4081 0.0000
ENSORLG00000014644 sv2bb 0.2876 0.2189
ENSORLG00000014670 slc17a9a 3.2270 6.8213
ENSORLG00000014673 LRRC52(2of2) 0.3378 0.6427
ENSORLG00000014798 vps8 12.1707 26.6421
ENSORLG00000014811 cyp27a7 0.1774 0.1688
ENSORLG00000014932 nt5e(1of2) 1.4675 2.4816
ENSORLG00000014942 atad1a 10.3360 0.0000
ENSORLG00000014988 abcc12 0.2196 0.0000
ENSORLG00000015149 adamts18 18.3555 9.5434
ENSORLG00000015165 zgc:162161 7.9848 12.7920
ENSORLG00000015284 rab11bb(1of2) 41.4360 43.6665
ENSORLG00000015350 clip2 8.6013 10.2766
ENSORLG00000015360 tat 4.0353 0.5583
ENSORLG00000015514 NoName 0.6748 0.0000
ENSORLG00000015540 racgap1 157.3527 57.8054
ENSORLG00000015707 si:dkeyp-110c7.4(1of2) 3.3471 1.2735
ENSORLG00000015733 CTSS(2of2) 433.8264 0.6663
ENSORLG00000015853 C3orf38 7.9447 7.9549
ENSORLG00000015962 NoName 2.6085 0.2757
ENSORLG00000016315 nr2f5 0.5732 0.2181
ENSORLG00000016388 hdac7b 0.1032 0.2944
ENSORLG00000016512 tfa 0.3048 0.1160
ENSORLG00000016536 nrip2 1.5134 0.0000
ENSORLG00000016606 rad23b(2of2) 147.4874 163.2942
ENSORLG00000016659 NoName 60.1106 59.2109
ENSORLG00000016707 si:dkey-88e18.8 0.3075 0.0000
ENSORLG00000016718 NoName 0.1409 0.0000
ENSORLG00000016741 msxe 13.3216 5.2662
ENSORLG00000016848 MEGF9 0.1603 1.3721
ENSORLG00000016853 NoName 0.0747 0.1421
ENSORLG00000016916 NoName 0.1908 1.0887
ENSORLG00000016942 gchfr 7.5563 3.5939
ENSORLG00000017060 nfe2l1a 2.2402 1.3394
ENSORLG00000017104 usp6nl 9.3099 12.1766
ENSORLG00000017108 agbl4 0.2044 0.3888
ENSORLG00000017231 ripk1l 23.2415 23.6167
ENSORLG00000017248 myo3b 0.0796 0.9088
ENSORLG00000017362 fdft1 43.9636 46.7932
ENSORLG00000017883 clul1 1.5316 0.6475
ENSORLG00000018176 cntnap5a 6.2632 0.4906
ENSORLG00000018215 prkag3b 0.6916 1.3158
ENSORLG00000020923 NoName 0.0000 0.0000
ENSORLG00000021171 NoName 0.0000 0.0000
ENSORLG00000021310 Y_RNA 9.6219 0.0000
ENSORLG00000021579 SNORA62 0.0000 0.0000
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Table 2. RPKM of the genes which have HNI specific HMDs in their 
promoters.  
Gene ID Gene name RPKM in d-rR RPKM in HNI
ENSORLG00000000055 slit1b 0.0316 0.0000
ENSORLG00000000313 lygl1 1.3207 0.0000
ENSORLG00000000403 si:ch211-240g9.1 0.0000 0.0000
ENSORLG00000000463 pygo2 25.1205 32.2708
ENSORLG00000000499 pitpnb 70.7332 64.9043
ENSORLG00000000540 INPP5A 3.6483 2.1690
ENSORLG00000000542 emilin1b 1.3526 4.0982
ENSORLG00000000548 VDAC3(1of2) 6.4160 4.7867
ENSORLG00000000758 hspb11(1of2) 0.0000 0.4449
ENSORLG00000000793 nde1 22.3312 18.7719
ENSORLG00000000801 nr2c2ap 53.5434 89.8793
ENSORLG00000000804 znf277 22.8568 25.3819
ENSORLG00000000905 rbfox3l 1.1105 4.0491
ENSORLG00000000950 NoName 0.4816 0.0000
ENSORLG00000001052 xylt1(1of2) 1.2229 3.3235
ENSORLG00000001152 NoName 7.0499 4.3589
ENSORLG00000001307 NoName 0.0000 1.2257
ENSORLG00000001446 ppiab 6.3199 3.6434
ENSORLG00000001510 NoName 4.3239 8.2260
ENSORLG00000001586 rel 12.7531 11.4378
ENSORLG00000001598 arhgap4b 1.9218 5.0714
ENSORLG00000001685 usp19 41.1792 22.2688
ENSORLG00000002023 AP3B2 4.0463 0.1673
ENSORLG00000002076 NoName 135.6203 258.8627
ENSORLG00000002212 nrm 1.4307 5.4437
ENSORLG00000002236 CLEC3B(1of2) 0.9729 6.4780
ENSORLG00000002298 NoName 0.0985 0.5620
ENSORLG00000002317 kcnh6a 0.1627 0.0774
ENSORLG00000002333 SLC39A3 42.5310 119.7607
ENSORLG00000002545 C2orf42 3.1925 7.3522
ENSORLG00000002571 rims1b 2.1086 7.8558
ENSORLG00000002997 fbp1b 0.3682 7.7054
ENSORLG00000003086 NoName 0.6554 1.6624
ENSORLG00000003099 hyal3 1.7975 0.2137
ENSORLG00000003156 lingo4a 0.0000 0.0000
ENSORLG00000003190 rasgrf2b 0.1695 0.0645
ENSORLG00000003346 C18orf8 16.3846 19.2566
ENSORLG00000003363 rhbdl3 0.3892 0.2468
ENSORLG00000003367 kcng3 0.2206 0.4197
ENSORLG00000003424 FIGN(1of2) 1.9252 1.0988
ENSORLG00000003657 NoName 0.7530 1.1460
ENSORLG00000003673 chd1l 5.7648 6.6333
ENSORLG00000003687 CSGALNACT1(1of2) 0.3617 0.1720
ENSORLG00000003722 PRSS23 0.2451 0.4662
ENSORLG00000003894 CELF2(1of2) 130.3021 185.4956
ENSORLG00000004195 ppih 119.2936 119.6126
ENSORLG00000004207 fam78bb 0.0000 0.0000
ENSORLG00000004237 lypd6 1.7582 4.4599
ENSORLG00000004268 rbfox2(1of2) 3.4511 8.9103
ENSORLG00000004398 XKR6(1of2) 0.5157 0.4905
ENSORLG00000004412 IFFO2 10.5506 1.2677
ENSORLG00000004415 BCAP29(1of2) 0.3162 0.6016
ENSORLG00000004671 grtp1a 36.2792 30.5028
ENSORLG00000004723 tyrp1b 0.0842 0.0000
ENSORLG00000004944 COLQ(1of2) 0.0000 0.4239
ENSORLG00000005044 amh 0.8501 5.3908
ENSORLG00000005065 inpp5kb 0.2674 0.5088
ENSORLG00000005450 HOMER3(1of2) 0.5466 3.3794
ENSORLG00000005497 nxnl2 0.3098 4.1261
ENSORLG00000005630 mcf2la 6.2056 22.2997
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Table 2 (continued)  
Gene ID Gene name RPKM in d-rR RPKM in HNI
ENSORLG00000005778 ZBTB7C 1.0575 2.3776
ENSORLG00000005873 RFESD(1of2) 12.9117 14.8525
ENSORLG00000005927 NoName 688.5746 205.5557
ENSORLG00000005990 zcchc8 65.3991 49.3559
ENSORLG00000006014 TCTN3 17.0466 13.7904
ENSORLG00000006079 slc22a6l 0.0845 3.8582
ENSORLG00000006354 ggact.2 12.0794 32.2967
ENSORLG00000006450 shbg 0.3007 1.1441
ENSORLG00000006454 cyp4f3 2.9168 14.1409
ENSORLG00000006547 neurl1b 3.0870 10.5000
ENSORLG00000007057 naa10 141.9277 168.1562
ENSORLG00000007325 ppp1r16a 32.7395 19.3132
ENSORLG00000007367 rnf13 20.0241 49.2444
ENSORLG00000007539 padi2(2of2) 5.1596 8.6220
ENSORLG00000007547 SVEP1 2.1389 4.3507
ENSORLG00000007762 fbxw7 23.2529 39.3220
ENSORLG00000007768 lgals3bpa 11.0685 1.0454
ENSORLG00000008091 MYO1E 24.6136 47.5657
ENSORLG00000008516 gpr31(1of2) 0.2948 0.2804
ENSORLG00000008863 gng2 3.3781 0.0000
ENSORLG00000009012 mapk12b 4.1546 6.6690
ENSORLG00000009111 TGFB3(1of2) 0.0954 0.1815
ENSORLG00000009155 si:dkey-266m15.5 10.9221 22.7989
ENSORLG00000009179 fuom 14.1224 16.7173
ENSORLG00000009218 TIMP3 4.5250 27.1171
ENSORLG00000009234 si:ch211-161h7.8 182.6892 195.1739
ENSORLG00000009473 ZC3H12A(1of2) 4.7369 11.9577
ENSORLG00000009487 cx39.9 0.4088 0.2592
ENSORLG00000009655 NoName 35.2372 41.0798
ENSORLG00000009687 tnk2b 0.3980 7.2351
ENSORLG00000009931 tbcela 8.4950 7.8882
ENSORLG00000010093 si:dkey-19e4.5 28.8426 17.8059
ENSORLG00000010300 P2RY2 0.1293 0.2459
ENSORLG00000010320 NoName 0.0000 0.0000
ENSORLG00000010446 NoName 0.1838 0.0000
ENSORLG00000010709 si:ch73-127m5.1 0.1923 0.0000
ENSORLG00000010726 mmp17b 0.9576 0.1822
ENSORLG00000010745 trdn 0.0000 0.0000
ENSORLG00000010844 fam83fb 0.3276 1.2464
ENSORLG00000010994 kif19 7.8797 23.4854
ENSORLG00000011034 gpr186 0.4409 0.2796
ENSORLG00000011206 dachd 1.3898 1.1941
ENSORLG00000011305 NoName 22.4814 83.2881
ENSORLG00000011393 cln5 6.7269 18.8045
ENSORLG00000011512 cacng6b 0.3771 3.5869
ENSORLG00000011532 syt14b 0.4390 0.1670
ENSORLG00000011726 camkk1a 8.2541 16.3310
ENSORLG00000011875 SSC4D 0.8501 1.9766
ENSORLG00000011907 hhatla 1.7950 0.8537
ENSORLG00000012181 NoName 0.1561 0.0000
ENSORLG00000012186 NoName 0.0000 0.0000
ENSORLG00000012428 NoName 48.7206 61.6463
ENSORLG00000012482 FHL2(2of2) 0.1647 0.0000
ENSORLG00000012690 NoName 17.6965 21.4685
ENSORLG00000012714 grin2aa 0.4975 2.9743
ENSORLG00000012758 bcl2l10 44.5684 79.9116
ENSORLG00000012858 MAT1A(2of2) 1.2141 2.3097
ENSORLG00000012895 slc2a6 0.2716 0.1722
ENSORLG00000013093 C1orf116 1.2096 2.9587
ENSORLG00000013122 pltp 1.0832 15.5486
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Table 2 (continued) 
 
 
 
 
 
 
Gene ID Gene name RPKM in d-rR RPKM in HNI
ENSORLG00000013190 C9orf172(1of2) 0.4171 0.2976
ENSORLG00000013258 TMEM229A 0.5826 1.6624
ENSORLG00000013293 NoName 0.2688 0.0000
ENSORLG00000013536 myh11a 1.9920 3.3218
ENSORLG00000013703 C17orf85 27.8851 37.2822
ENSORLG00000013751 fundc1 86.6177 55.5254
ENSORLG00000014110 lgi3 0.4989 0.0000
ENSORLG00000014204 ldlrap1a 2.4347 11.0009
ENSORLG00000014434 lrrc3 0.0000 0.0000
ENSORLG00000014485 HEPACAM(2of2) 0.5649 0.0000
ENSORLG00000014564 PDPR 16.4770 31.5463
ENSORLG00000014584 ggt5a 0.5138 1.4663
ENSORLG00000014639 CCDC134 6.0029 12.6015
ENSORLG00000014694 NoName 0.0000 1.3014
ENSORLG00000014855 has3 3.3051 9.5122
ENSORLG00000015086 kcnj1b 1.5045 0.2385
ENSORLG00000015155 rev3l 20.2256 34.4790
ENSORLG00000015474 tldc1 52.2080 41.9648
ENSORLG00000015577 anapc13 47.6781 14.0317
ENSORLG00000015735 cbln11 0.0000 0.0000
ENSORLG00000015785 FAM177B 0.0000 1.2525
ENSORLG00000015895 SPTBN1(2of3) 0.3644 0.0000
ENSORLG00000015981 myl1 0.0000 3.4391
ENSORLG00000016178 kcng1 0.3793 0.9020
ENSORLG00000016228 pusl1 5.5149 2.1521
ENSORLG00000016234 zdhhc22 0.3572 0.3398
ENSORLG00000016244 paqr6 0.5519 1.4700
ENSORLG00000016454 cnot2 32.5479 45.5099
ENSORLG00000016609 AMDHD1 1.4339 2.0985
ENSORLG00000016638 gpr55a 0.2870 0.0000
ENSORLG00000016750 NoName 9.7005 1.3471
ENSORLG00000016871 zgc:194887 0.2191 3.3349
ENSORLG00000016897 C2CD4C(2of2) 0.1363 0.0000
ENSORLG00000017095 C15orf52 0.6949 1.3220
ENSORLG00000017219 NoName 1.3933 1.6372
ENSORLG00000017301 tspan4b 0.1554 0.0000
ENSORLG00000017367 KCNMB4 0.4611 8.3332
ENSORLG00000017368 NoName 49.2462 35.4681
ENSORLG00000017415 matk 0.2221 0.0000
ENSORLG00000017918 ackr4a 1.4345 0.4962
ENSORLG00000018069 chga 1.4961 0.4379
ENSORLG00000018199 ahr1b 0.0797 0.1517
ENSORLG00000021061 NoName 0.0000 0.0000
ENSORLG00000021195 NoName 0.0000 0.0000
ENSORLG00000021244 NoName 0.0000 0.0000
ENSORLG00000021563 SNORA62 0.0000 0.0000
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6mer 
ratio of 
MI 
enrichment periodicity 
matched known motifs 
(q value < 0.1) 
CGCGAC 0.295 6.021    weak 
 
GCGCGA 0.296 9.754    weak 
 
CGCGCG 0.315 48.092    weak Zfp161,E2F2,E2F3 
TCGCGA 0.359 5.200    intermediate ZBTB33 
CGCGGA 0.360 11.797    No 
 
CGCGAG 0.364 9.981    weak ZBTB33 
CCGCGG 0.364 8.035    No 
 
CCGCGC 0.386 13.042    weak Zfp161 
CGCTAG 0.388 3.302    strong 
 
TCCGGA 0.391 3.228    No Spdef 
CACGTG 0.400 2.606 No 
Mycn,Arnt,MYC::MAX,Max,Bhlhb2, 
Bhlhe40,USF1,Myc,HIF1A::ARNT,USF2 
ACCGGA 0.412 3.175    weak Gabpa 
CCGGAG 0.419 3.363    No 
 
TCCGAA 0.420 2.367    No 
 
CCGGAA 0.427 3.726    intermediate Gabpa,ELK4,ELK1,Ehf 
CGCGCC 0.435 11.455    weak E2F3,E2F2,Zfp161 
ATCCGG 0.446 2.328    No Spdef 
CGCGCA 0.450 15.178    weak Zfp161 
CGCGGC 0.450 9.141    weak 
 
GCGCGC 0.455 24.526    weak E2F2,E2F3,Zfp161 
 
Table 3. The list of the possible transcription factors which could bind to 
selected top 20 6-mers with CpGs. 
For each 6-mer, the ratio of mutation index (common HMDs / Hd-rR specific 
HMDs), enrichment level within the common HMDs (frequency in common 
HMDs / frequency in methylated regions) and the intensity of periodicity of 
DNase-seq signal around itself are also shown. 
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6mer 
ratio of 
MI 
enrichment periodicity 
matched known motifs 
(q value < 0.1) 
GCTAGC 0.335 4.486    strong 
 
GCTAAC 0.498 2.650    strong 
 
AGCTAG 0.502 2.525    strong 
 
CTTACC 0.527 1.407    No 
 
GGTCAC 0.588 1.059    No 
ESRRA,PPARG,Rara,NR4A2,ESR1,USF1, 
Nr2f2,USF2,ESR2 
GGCCAC 0.597 1.002    No 
 
GACCCC 0.608 1.126    No Glis2,Hnf4a,Esrra,Rxra,Zfp281,Rara, 
GGTCCA 0.619 1.040    No 
 
CCATGC 0.620 0.885    No 
 
GGGATA 0.620 0.928    No 
 
TAGCTA 0.628 2.359    strong 
 
GGTACC 0.630 1.168    No Plagl1 
CTTGCC 0.633 0.810    No 
 
ACTTCC 0.640 1.184    intermediate 
ELF1,Gabpa,Spi1,Erg,FLI1,Sfpi1,Ehf,ELK4, 
Ets1,Ehf,ELF5,FEV,Elf3, 
GGCACC 0.641 1.234    No 
 
AGGTAA 0.641 1.136    No 
 
AAGGTA 0.643 0.890    No 
 
GCATAC 0.644 0.788    No 
 
GGATCC 0.652 1.373    No 
 
GGGGGA 0.664 1.705    No Obox2,Pitx3,Obox3,Zfp740,MZF1,Zfp281 
 
Table 4. The list of the possible transcription factors which could bind to 
selected top 20 6-mers without CpGs. 
For each 6-mer, the ratio of mutation index (common HMDs / Hd-rR specific 
HMDs), enrichment level within the common HMDs (frequency in common 
HMDs / frequency in methylated regions) and the intensity of periodicity of 
DNase-seq signal around itself are also shown. 
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Name Sequence 
GFP-F ATGGTGAGCAAGGGCGAGGAG 
GFP-R GGTGGCGACCGGTGGATCCA 
bactPro-InF-F CCACCGGTCGCCACCGCAGGAATTCAATTACAGTG 
bactPro-InF-R GCCCTTGCTCACCATGGCTAAACTGGAAAAGAACA  
HdrRsp1-InF-F TAGTGGATCCACCGGGGTCCTGCTCACCTGTTTCT 
HdrRsp1-InF-R TGCGGTGGCGACCGGTTGACTTCTGTTGTGAAGTTAGATG 
HNIsp1-InF-F TAGTGGATCCACCGGTCAACCAAATATTAGTAATGACCCTTT 
HNIsp1-InF-R TGCGGTGGCGACCGGTGCACCACTAAGGTTAAATTGG 
HNIsp2-InF-F TAGTGGATCCACCGGTCTGATGAACAAGGAAAAACCA 
HNIsp2-InF-R TGCGGTGGCGACCGGTTCCAGACCTCCCTCAGAAATG 
HNIsp3-InF-F TAGTGGATCCACCGGGAAAACAAACGGACCCTCAG 
HNIsp3-InF-R TGCGGTGGCGACCGGAGGTCAAAGGCTAAAGGTTACT 
common1-InF-F TAGTGGATCCACCGGACATGTTTGATGTCTCAAGCTAC 
common1-InF-R TGCGGTGGCGACCGGCCACTGAAAGGTCCAGATTCA 
common2-InF-F TAGTGGATCCACCGGTGCAATAAAGCAAATAACTTAAAGGAC 
common2-InF-R TGCGGTGGCGACCGGGAATCCCGATTGTTTTAGAATG 
common3-InF-F TAGTGGATCCACCGGTCTTCACATTGCTGGAACTGAC 
common3-InF-R TGCGGTGGCGACCGGACAAAGCCCGTCACCTACTG 
 
Table 5.  Primers used for making transgenic medaka (for cloning of HMD 
sequences and amplification of b-actin and GFP sequences)  
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Name Sequence 
bactPro-seq-F1 TTAGAAGGTAACATCATCTG 
bactPro-seq-F2 AAGCCACGAATGAATTTAAG 
bactPro-seq-F3 TGAGGTGGCATTCTGCTTTC 
bactPro-seq-F4 TAGCAGAATTTTGTGGCCAC 
bactPro-seq-F4-2 AATTGGAGGTGACCATTAGC 
bactPro-seq-F5 GTGTAACAATGGGAGGGAAC 
GFP-seq-F1 GTTCGAGGGCGACACCCTGG 
GFP-polyA-seq-F1 GGTGGTGCAGATGAACTTCA 
M13R_bef_seq TCCGGCTCGTATGTTGTGTG 
HdrRsp1_seq_F1 CTCAGCATCTCATCCTGGAG 
HdrRsp1_seq_F2 ATGGAAAATAATGGGAGCAC 
HdrRsp1_seq_F3 GAGAAATGAAGACGTACATG 
HdrRsp1_seq_F4 CCTTTTGTTCTGGAAACATG 
HdrRsp1_seq_F5 GGATCACTGAACACTGACAG 
HdrRsp1_seq_F6 CTTCGTCAATTGAATAATAATATG 
HNIsp1_seq_F1 TTAAGTGAATTTCTAGAAC 
HNIsp1_seq_F2 AGGGGATCAGAAATATAAAC 
HNIsp1_seq_F3 CGCAACATCTCGGCTGGCTG 
HNIsp1_seq_F4 GCCATCCACAAGACAAAAC 
HNIsp1_seq_F5 ACTTTCCCCGCTGGGATTTC 
HNIsp1_seq_F6 TGTCCTTCCTTCTGTACAG 
HNIsp2_seq_R1 AATATGGTGCTTAACCTTGG 
HNIsp2_seq_R2 CCAAATCTGCCTATAAACTC 
HNIsp2_seq_R3 ATTGTGGCCTACTGCGCCATG 
HNIsp2_seq_R4 CCTCATTTTATTATGAAAGG 
HNIsp2_seq_R5 TAGGTAAACTATAAAAGTTG 
HNIsp2_seq_R6 AAAGTTTGGTGTTATGTTGC 
HNIsp2_seq_R7 AGGTACTTCTGCGAGGCGTC 
HNIsp3_seq_R1 TGCACATGTGCAGACGGGAC 
HNIsp3_seq_R2 TTCTCCCCGTCTGCATGGAG 
 
Table 6.  Primers used for making transgenic medaka (for confirmation of 
the sequences of the constructs) 
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Name Sequence 
HNIsp3_seq_R3 CTCGGTAGCTGCGTGCCTTG 
HNIsp3_seq_R3-2 CGGTGGTTGGCGTGATATG 
HNIsp3_seq_R4 ATACTAACGTCCACTCAAAG 
HNIsp3_seq_R5 TCTTCCTCTTCATCAGGGAG 
HNIsp3_seq_R6 AAGCCGCACAGCTCTGCATC 
common1_seq_R1 TCTGTTGGCTCAGTTGTTGG 
common1_seq_R2 CGCTTGCAATGTCGGTGATG 
common1_seq_R3 AATCCACATTTACGCGTAGC 
common1_seq_R4 TCTGTTGGCTCAGTTGTTGG 
common1_seq_R5 AAGGTTACACAAACTAACTC 
common1_seq_R5-2 GAATGCTACAATCACAGAGG 
common1_seq_R6 CAAAAGTGTCAGAAAACGTC 
common2_seq_F1 TAGTTCCCTGTTTGGAGCTC 
common2_seq_F2 GTCTTTTAATAAGGATAATG 
common2_seq_F3 TAAAATCAAGTTTGGCTGTC 
common2_seq_F4 CATTCGCCGGGCTAGACCAC 
common2_seq_F5 CACAAGTTATGTAAAAAGAC 
common2_seq_F6 TTCACCACAAATACTCAGAG 
common2_seq_F7 CCCACATGTGGGGAAACAAG 
common3_seq_R1 TCAGTCAGGGTGGCAGCGTC 
common3_seq_R2 GCCTCAGTTAAAACCTAGAG 
common3_seq_R3 AACTGTTATCTCCCATTAGG 
common3_seq_R4 CGTAAACTAATTGTGTTTTC 
common3_seq_R4-2 ACTTCAAGTACTGCAAAATC 
common3_seq_R4-3 TCTATTGAAGTGTTCTAATC 
common3_seq_R5 TAGAAACTAAGCAAGCCACG 
common3_seq_R6 TACCCAAAGGTACAGCAAAG 
common3_seq_R7 TATTGCTGCTTTTTAGCTGG 
 
Table 6 (continued) 
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Name Sequence 
HdrRsp1_bs_F TTTTGTGTATTTTTTATTATTAGAAAAATG 
HdrRsp1_bs_R AAAAACCTCTCCAACCTCAATAAC 
HNIsp1_bs_F TGGATTTGATATATATTTTAATTGT 
HNIsp1_bs_R TAAAACTACAAAACTCTAACACCTC 
HNIsp2_bs_F GGATGTTATAGGTGATTATTGGTTTG 
HNIsp2_bs_R CCTTAAAACTCCAACTTAACACAATTT 
HNIsp3_bs_F GTGTTGTTGTTTATTTTTTTGAT 
HNIsp3_bs_R TTTTCCTACAAATACTATCTTCCCC 
common1_bs_F GTTTATTTTTTTATTTATTTGATTAG 
common1_bs_R CAAATTTTACCCCCATAATTAACTC 
common2_bs_F GAGGAGTTAGAATTTTTTTAAAATTT 
common2_bs_R ATACTACTTTAACTCCAATACATCC 
common3_bs_F TGGTTGGAAGTAGTATAGTTTAGAAAA 
common3_bs_R CATACATCACCATCTTCAACAAAAC 
HNIsp1R_bs_F TTTTAAAGAAAGTGTGAAATTAGGATG 
HNIsp1R_bs_R AAATCTTAACAAAAATCACATAACC 
HNIsp2L_bs_F GTTGAAGGTTTGTGAATTTGAATTT 
HNIsp2L_bs_R TCCAAACAACAATATAACCACTACC 
HNIsp2R_bs_F TTTATGTGAGGATGAAGGTTAGTAGG 
HNIsp2R_bs_R AACCTCCCTCAAAAATACAAAATAC 
common1L_bs_F TGGGGAATAGTTGGTGTAGTTAGTT 
common1L_bs_R ATAAAATCTTTAATCCACTTTCTTACCC 
common1R_bs_F TTTTGATTTGATTTGAATTGGAATT 
common1R_bs_R TAAATAATCTTCCACCAACTATAAA 
common2L_bs_F ATTTGGAGTAGGTGAAAAATGTTGT 
common2L_bs_R AAATTACAAACCCAATTCAATCATC 
common2R_bs_F TTGTAGTTTTTTTTGTTTGAAATAG 
common2R_bs_R CAAATCTCTAAACTCCAACTTCCTAC 
zicA_bs_F TTGTGTGGGTAGTATAGTTATTTTGAG 
zicA_bs_R CCTAATAACAAAACATAAAATCTTTTT 
zicB_bs_F GGATTTTGTTTTAGGTTTTTTAGT 
zicB_bs_R CCATTAATCTCTACATATATACATTTTT 
zicC_bs_F GTTGGTAGTTGTAATTTTTATGGGG 
zicC_bs_R CCCAATTAATAACCCTTCAATTAACT 
Table 7.  Primers used for bisulfite analysis 
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